(310 items) - gujarat state portal · 5 of 51 73 1208 misoprostol tab. 200 mcg. 106300 74 1213...
TRANSCRIPT
1 of 51
TENDER DOCUMENT
FOR
TABLET,CAPSULES,
INJECTION,MISCELLANEOUS,
&
SURGICAL ITEMS
(310 ITEMS)
T.E.NO.GMSCL/D-629/RC/2018-19
Gujarat Medical Service Corporation
Limited
(A government of Gujarat Undertaking)
2 of 51
Index
SR.
NO
CONTENTS PAGE
A. GENERAL INSTRUCTIONS FOR BIDDERS 12
B ELIGIBILITY CRITERIA 13
C TECHNICAL BID 15
D GENERAL TERMS AND CONDITIONS OF TENDER 16
E COMMERCIAL BID 20
F OPENING OF TECHNICAL AND COMMERCIAL BID 20
G ACCEPTANCE OF BID 21
H SECURITY DEPOSIT 21
I AGREEMENT 22
J SUPPLY CONDITIONS 22
K SHELF LIFE 24
L PACKING AND LOGOGRAM 25
M QUALITY TESTING 28
N PAYMENT PROVISION 29
O FALL CLAUSE 31
P STANDARD BREACH CLAUSES 31
Q INSPECTION 32
R WARRANTY CLAUSE 32
S JURISDICTION 32
ANNEXURE- I 33
ANNEXURE-II 34
ANNEXURE-III 35
ANNEXURE-IV 36
ANNEXURE-V 38
ANNEXURE-VI 39
ANNEXURE-VII 40
ANNEXURE-VIII 41
ANNEXURE-IX 42
ANNEXURE –X 43 to 45
ANNEXURE-XI 46
ANNEXURE-XII 47
ANNEXURE-XIII 48
BIDDING SCHEDULE 50 to 51
3 of 51
Tender Notice
Tender Notice No.: GMSCL/ D-15 /2018-2019
Tender Brief
Tenders are invited online (through internet) from reputed manufacturers / direct importers for
supply of following drug items for period of two years on Rate contract basis as mentioned in
the tender details section.
Tender Details
GUJARAT MEDICAL SERVICES CORPORATION LIMITED
Block No.14/1, Dr. Jivraj Mehta Bhavan, Sector-10,
Gandhinagar.℡ 23250766 / 67 / 70
TENDER NOTICE: D-15/2018-2019 Tenders are invited online (through internet) from reputed Manufacturers / Direct importers for purchase of following items on rate contract basis. All tender documents canbe downloaded free from web site http://gmscl.nprocure.com between 17/04/2018 to 07/05/2018 up to15.55 Hrs
TENDER ENQUIRY NO-GMSCL/D-629/RC/2018-19(ON RATECONTRACT BASIS)
TENDER ENQUIRY NO-GMSCL/D-629/RC/2018-19(ON RATE CONTRACT BASIS)
ITEM: : Tablet ,Capsule ,Miscellaneous & surgical items
Document Fee: 15000/-
E.M.D. : Item wise EMD as shown below
Sr No.
Itemcode Name of Item EMD (Rs.)
1 1001 Acetazolamide Tablets 250 mg 28700
2 1005 Acyclovir Tablets 200mg 84400
3 1006 Albendazole Tablets400 mg 785700
4 1012 Amitriptyline HCL Tablets 25mg 50300
5 1013 Amlodipine Tablets 5mg 121400
6 1016 Amoxycillin Capsules 500 mg 5153900
7 1017 Amoxycillin Capsules 250 mg 1911800
8 1018 Amoxycillin Dispersible
Kid Tablets 125 mg 756000
9 1021 Ascorbic Acid Tablets 500mg 910800
10 1023 Atenolol Tablets 50 mg 417900
11 1025 Benzhexol Tablets (Trihexyphenidyl) 2mg 20000
12 1026 Bisacodyl Tablets 5mg 98100
13 1031 Carbamazepine Tablets 200 mg 288000
14 1034 Cefadroxil Kid Tablets 125mg 639400
15 1039 Chloroquine Tablets250 mg 646100
16 1040 Chloroquine Tablets 500mg. 20300
17 1041 Chlorpheniramine Maleate Tablets 4mg 615500
18 1051 Clotrimazole Vaginal Tablets 100 mg 151800
19 1059 Dexamethasone Tablets 0.5 mg 193000
20 1060 Diazepam Tablets 5 mg 32600
21 1061 Diclofenac Sodium Tablets 50mg 1427600
22 1062 Dicyclomine Tablets 20mg 209000
23 1063 Diethylcarbamazine CitrateTablets 100 mg 7500
24 1064 Digoxin Tablets 0.25 mg 23300
4 of 51
25 1065 Diloxanide Furoate Tablets 500mg 25000
26 1068 Domperidone Tablets 10 mg 231900
27 1071 Doxycycline Capsules 100mg 851300
28 1072 Enalapril Tablets 5 mg 267700
29 1075 Eteophylline& Theophylline Tablets 444300
30 1081 Ferrous Sulphate Tablets 200mg 154300
31 1083 Fluoxetine Capsules 20 mg 73100
32 1084 Folic Acid & Ferrous Sulphate Tablets (Small) 154000
33 1086 Folic Acid Tablets 5mg 462000
34 1087 Frusemide Tablets 40mg 111400
35 1093 Haloperidol Tablets 5mg 5000
36 1096 Ibuprofen Tablets 400mg 1751400
37 1100 IsosorbideDinitrate Tablets 10mg 44000
38 1107 Mefloquine Tablet 250Mg 300
39 1108 Metformin Tablets 500 mg 1135300
40 1110 Methyldopa Tablets 250 mg 63700
41 1112 Metoclopramide Tablets 10mg 12500
42 1113 Metronidazole Tablets 400 mg 1859400
43 1114 Metronidazole Tablets 200mg 279400
44 1119 Norethisterone Tablets 5mg 42500
45 1120 Norfloxacin Kid Tablets 100mg 99400
46 1121 Norfloxacin Tablets 400 mg 1108100
47 1124 Ofloxacin Tablets 200mg 686000
48 1127 Paracetamol Tablets 500mg 4358000
49 1134 Prednisolone Tablets 5 mg 228500
50 1135 Primaquine Tablets 2.5 mg 14700
51 1148 Quinine Tablets 300 mg 12100
52 1149 Quinine Tablets 100 mg 5200
53 1152 Risperidone Tablets 2mg 59500
54 1154 Salbutamol Tablets 4mg 72800
55 1155 Sodium Valproate Tablets 200 mg 1034400
56 1156 Sodium Valproate Tablets 500 mg 249100
57 1158 Spironolactone Tablets 25 mg 261700
58 1167 TrifluoperazineHCL Tablets 5mg 18100
59 1168 Trimethoprim&Sulphamethoxazole Tab 480 mg 1403600
60 1171 Vitamin A Capsules 50,000 IU 105300
61 1172 Vitamin A Capsules 2,00,000 IU 198000
62 1173 Vitamin B Complex Tablets (Therapeutic) 2181100
63 1178 Fluconazole Tablets 50mg 92500
64 1182 Salbutamol Rotacaps 200mcg 32600
65 1185 Azithromycin Tablets 500 mg. 4958600
66 1198 Atorvastatine Tablets 10 mg 458600
67 1199 Cefixime Tablet 200mg 3848600
68 1200 Diclofenec Sodium Suppository 12.5mg. 27300
69 1202 EsCitalopram Oxalate Tablets 10 mg 56100
70 1203 Lorazepam Tablet 2mg 35800
71 1204 Metoprolol Tablets 25mg 120900
72 1205 Olanzapine Tablet 5mg 48500
5 of 51
73 1208 Misoprostol Tab. 200 mcg. 106300
74 1213 Paracetamol Kid Tablets 125mg 175300
75 1214 Aceclofenac Tablets100 Mg 436100
76 1218 Levofloxacin Tablets 500mg. 786500
77 1221 Losartan Potassium Tablets 50mg. 142800
78 1224 Pantoprazole Tablets 40mg. 1286800
79 1226 Glimepiride Tablets1mg. 103500
80 1230 Artemether & Lumefantrine Tablets 12100
81 1240 Spironolactone Tablets 100 mg 108200
82 1242 Clopidogrel Tablets 75 mg 158000
83 1243 Levothyroxine Tablets 50mcg 1000
84 1244 Levothyroxine Tablets 100mcg 1000
85 1249 Tramadol Capsules 50 mg 82200
86 1250 Tramadol Capsules 100 mg 33600
87 1251 Zinc Sulphate Dispersible Tablets 20mg 116900
88 1253 Deferasirox Tablets 250 mg 277500
89 1254 Deferasirox Tablets 500mg 1137300
90 1257 Atorvastatin Tab. 40mg. 410500
91 1258 Bisacodyl Suppository 37600
92 1260 Diclofenac Sodium Suppository 50mg. 27600
93 1262 Ferrous Sulphate and Folic Acid Tablets 100 mg + 0.5 mg 1805300
94 1268 Oseltamivir Capsule 75 mg 2328100
95 1266 Acetyl Salicylic Acid Tablet 350 mg 10600
96 1269 Nifedipine Sustain Release Tab. 10mg 37700
97 1270 Carvedilol Tablet 12.5mg 32700
98 1271 Fluconazole Tablet 150 mg 670800
99 1272 Cefadroxil Tablet 500 mg 28427200
100 1273 Iron Folic Acid (IFA) Tablet (Small)pink 2145200
101 1276 Famotidine Tablets 40 mg 1099800
102 1277 Famotidine Tablets 20 mg 907000
103 1300 Clobazam Capsule 5mg 188200
104 1307 Kit3/ White Clr Benzathine Penicillin Inj & Azithromycin Tab 1000
105 1312 Oseltamivir Capsule 30 mg 36700
106 1321 Tab. Aripiprazole 15 mg 20800
107 1326 Tab. Methyl Phenidate 10 mg 11100
108 1328 Tab. Atomoxetine 18 mg 13600
109 1336 Cap. Atazanavir 300mg 1000
110 1340 Tab. ZL Baby (Zidovudine 60mg + Lamivudine 30mg) 1000
111 1342 Tab. Nevirapine 50mg 1000
112 1343 Tab. Lopinavir 100mg & Ritonavir 25mg. 1000
113 1344 Abamune L Baby(Abacavir 60mg&Lamivudine 30mg) 1000
114 1352 Tab.Nitazoxanide 500 mg 1000
115 1357 Levothyroxine Tablets 25mcg 1000
116 1358 Labetalol Tablet 50 mg 1000
117 1360 Oseltamivir Capsule 45 mg 36700
118 2003 Amikacin Sulphate Injection(For IM/IV Use) 500mg 853400
119 2004 Amikacin Sulphate Injection(For IM/IV Use) 100mg 60100
120 2005 Aminophylline Injection(For IV Use) 2.5% w/v 18800
6 of 51
121 2007 Amoxycillin & Clavulanic Acid Injection 300mg 80200
122 2010 Ampicillin Sodium Injection 500mg(IM/slow IV use) 74000
123 2012 Anti-D (RHO) Immunoglobulin (Human) Injection 300mcg (liquid
Form) 1503400
124 2013 Artemether Injection 80 mg 11400
125 2014 AtracuriumBesilate Injection 10 mg/ml 139400
126 2015 Atropine Sulphate Inj. (1ml Ampoule) 74000
127 2019 Bupivacaine HCLInjecton (20ml Vial) 64000
128 2023 Cefazoline Sodium Injection 500 mg 31600
129 2027 Ceftazidime Injection 1 Gm 40300
130 2029 Ceftriaxone for Injection 500 mg 146800
131 2031 Chloroquine Phosphate Injection 40 mg/ml 18400
132 2032 Pheniramine Maleate Injection (For IM/IV Use) 123300
133 2039 Dexamethasone Sodium Injection 4 mg/ml 262800
134 2046 DiatrizoateMaglum.&Diat. Sod.Inj. 60% 13100
135 2047 DiatrizoateMaglum.&Diat. Sod.Inj. 76% 71300
136 2048 Diazepam Injection 5 mg/ml 62800
137 2049 Diclofenac Sodium Injection 25 mg/ml 423500
138 2050 Dicyclomine Injection 20 mg/2 ml 69300
139 2056 Dobutamine Injection 50 mg/ ml 81900
140 2057 Dopamine Injection 40 mg/ ml 76400
141 2059 Eteophylline & Theophylline Injection 153000
142 2061 Fentanyl Inj.50mcg/ml, 2ml Amp. 1000
143 2065 Frusemide Injection 10 mg/ml 90000
144 2073 Haloperidol Injection (For IM/IV Use) 4900
145 2074 Heparin Injection 5000 i.u./ml 429100
146 2075 Hepatitis B Vaccine 10mcg/0.5 ml (1ml Amp) 38900
147 2076 Hepatitis B Vaccine 10mcg/0.5ml (10ml Vial) 18600
148 2079 Hydrocortisone Sod.SuccinateInj 100mg 243400
149 2088 Ketamine Hydrochloride Injection 50 mg. (Deep IM/slow IV use) 105400
150 2090 Lignocaine & Adrenaline Injection 30 ml Vial 25900
151 2097 LyophilisedAntisnake Venom Serum (Powder) 2220000
152 2107 Inj. Mephenteramine 15 mg/ml Via 12100
153 2108 Methotrexate Injection 50 mg/2 ml 1000
154 2109 Methyl Ergometrine Maleate Inj 0.2 mg/ml 38400
155 2111 Metoclopramide Injection 5 mg/ml 10600
156 2117 Inj. Gas Gangrene Antitoxine 108000
157 2122 Neostigmine Inj 0.5 mg/ml (1ml Ampoule 53900
158 2128 Paracetamol Injection 150 mg/ml 277900
159 2129 Pentazocine Injection 30 mg/ml 77300
160 2135 Pralidoxime Chloride Injection 1Gm 331700
161 2138 Promethazine HCL Injection. 21100
162 2141 Quinine DihydrochlorideInj 300mg/ml 7800
163 2143 Ranitidine Injection 50 mg/2 ml 472000
164 2145 Sodium Bicarbonate Injection 7.5% w/v 29400
165 2151 Sterile Vancomycin Injection 0.5 gm 322000
166 2153 Sterile Water for Injection (5ml) 249300
167 2160 Immunoglob.T.T. Human Injection 250 IU 364500
7 of 51
168 2162 Tetanus Toxoid (Adsorbed) Injection 634000
169 2164 Thiopentone Injection 500 mg 41600
170 2168 Vecuronium Bromide Injection 4 mg/ml 83600
171 2173 Vitamin B Complex Injection (For IM Use) 72600
172 2186 Vecuronium Bromide Injection 4 mg/ml 293200
173 2190 Vitamin B12 Injection 61000
174 2195 Glycopyrrolate Injection (0.2mg/ml) 71700
175 2197 Iohexol Injection 300mg/ml (50ml vial) 130100
176 2198 Methyl Prednisolone Sod.Succ.Inj. 500mg 497600
177 2203 Sodium Chloride(Normal Saline) Inj 100 ml 801600
178 2213 Meropenem Injections 500mg 502200
179 2214 Levofloxacin Injections (500mg./100ml) 207400
180 2215 Aciclovir Injections 250mg. (Dry Powder) 73400
181 2217 Fat Emulsion Injections 20% w/v (PL/TG Ratio 0.06) 250ml 79200
182 2219 Amino Acid 10% Injection 248500
183 2227 Enoxaparin Sodium
Injection 60mg/0.6ml 682400
184 2228 Iron & Sucrose Inj.5ml/Amp. 875200
185 2229 Sulbactum & Cefoperazone for Injection 1gm 529600
186 2242 Tramadol Injection 50 mg / ml 116800
187 2248 Atropine Sulphate Injection 0.6mg/ml, 30ml Vial 55700
188 2250 Cisplatin Injection 10 mg (Intravenous Infusion) 5900
189 2251 Cisplatin Injection 50 mg(Intravenous Infusion) 73700
190 2254 Hydroxyethyl Starch 6% w/v (Intravenous Infusion) 107400
191 2255 Phytomenadione (Vit.K1) Inj. (1mg/1ml) 199000
192 2258 Bupivacaine Hydrochloride in Dextrose Injection 5mg + 80mg per
ml 50000
193 2271 Filgrastim 300mcg Injection 35500
194 2275 Inj. Valethamate Bromide 23900
195 2290 Inj Lorazepam 2ml 9700
196 2291 Olanzapine Inj. (for IM use) 1000
197 2292 Inj Flupenthixol Depot 2ml 56200
198 2293 Inj Clopixol depot 20mg(Zuclopenthixol injection) 38400
199 2294 Deferoxamine mesylate inj 500 mg 729300
200 2300 Ulinastatin for injection 1,00,000 IU 342000
201 2303 Nadroparin Injection 0.6 ml 45000
202 2310 Inj Ganciclovir 600 mg 1000
203 2311 Sodium Chloride (Normal Saline) Inj 1000 ml. 1000
204 2312 Cyclophosphamide injection 1 GM 1000
205 2313 Fluro-Uracil Injection 500 mg/10 ml. 1000
206 2314 Inj Balance salt solution(Glass bottle) 500 ml 1000
207 3002 Albendazole Suspension 200 mg/5 ml 10 ml Bottle 277800
208 3013 HbsAg-Rapid Test Kit(Australia Antigen Kit) (RPHA) 213200
209 3015 Betamethasone Cream 0.05% 903000
210 3024 Chloroquine Phosphate Syrup 100 mg/10ml 64200
211 3026 Cholecalciferol Granules (Vitamin D3) 198000
212 3028 Clotrimazole Cream 1% 941900
213 3029 Compound Benzoic Acid Ointment (Whitefield's oint.) 635000
214 3030 Vitamin A Solution Conc.1 Lac IU/1ml 591500
8 of 51
215 3033 Dextromethorphan Syrup 13.5 mg/ 5 ml 1832800
216 3037 DicyclomineHCL Oral Solution 10 mg/5ml 172600
217 3065 Halothane Liquid 250ml Bottle 69000
218 3068 Hydrogen Peroxide Solution 200 ml Bottle 74800
219 3070 Ibuprofen Suspension 100 mg/5 ml 269800
220 3073 Isoflurane Liquid (100 ml) 43200
221 3088 Paracetamol Syrup 125 mg/5 ml 1179200
222 3090 Petroleum Jelly (White) 296900
223 3100 Povidone Iodine Solution 5% 1 Litre Jar 355000
224 3105 Salbutamol Syrup 2 mg/5 ml 100ml Bottle 522300
225 3106 Sevoflurane Liquid 250 ml Bottle 1389500
226 3107 Silver Sulphadiazine Cream 1% 500 gm Jar 616500
227 3109 Sodium Hypochlorite Solution 5 Liter Jar 1000
228 3111 Strips for esti.ofAlbu& Glu.in Urine 1000
229 3114 Timolol Maleate Eye Drops 0.25% 13400
230 3117 Trimethoprim &SulphamethoxazoleSusp. 614200
231 3131 Calamine Lotion 279700
232 3138 HCV Elisa Test Kit (upto 96 Test) 178700
233 3139 HCV Rapid Test Kit (upto 100Test) 202700
234 3142 Povidone Iodine Ointment 5% (20gm Tube) 775800
235 3143 Pregnancy Test Kit (upto 50 Test) 333400
236 3157 Serum VDRL Test Kit (100 Tests) 66300
237 3158 Serum Widal Estimation Kit (4x5ml) 20400
238 3159 Silver Sulphadiazine Cream 1% (20gm tube) 314200
239 3162 Azithromycin Oral Suspension 200mg/5ml 516700
240 3168 Diazepam Rectal Solution 2mg/ml 1000
241 3175 Compound Benzoin Tincture 500 ml Bottle 78200
242 3183 Clobetasol Propionate Cream 614500
243 3200 Levocetirizine Dihydrochloride Syrup 30 ml Bottle 667800
244 3202 Permethrin Cream 5% 30gm. tube 82800
245 3203 Lactulose Solution 100 ml Bottle 334100
246 3207 Cephalexin Syrup 125 mg / 5 m 358900
247 3209 Glycerine 100 ml Bottle 91500
248 3211 Magnesium Sulphate Powde 5900
249 3214 Petroleum Jelly (White) 30 gm Tube 367900
250 3216 Zinc Gluconate Syrup 20 mg / ml 301200
251 3224 Cyclopentolate Eye Drop 5ml 21000
252 3225 Lignocaine HCL Jelly 5%, 30gm Tube 211500
253 3227 Moxifloxacine Eye Drop 5ml 961700
254 3230 Prednisolone Acetate Eye Drop 0.1%, 5ml 1000
255 3231 Tobramycine Eye Drop 03% w/v 10ml 1000
256 3232 Iron Folic Acid (IFA) Syrup 457600
257 3234 Dianoprostone Gel 3%, 3gm. Tube 537400
258 3236 Clotrimazole with Beclomethasone Drops 1% 256400
259 3237 Neomycin, Hydrocortisone &Polymixin B Ear Drops 418300
260 3238 Brimonidine Tartrate and Timolol Eye Drops 0.15% + 0.5% 91800
261 3240 Tobramycin and Dexamethasone Ophthalmic Suspension
0.30%+0.10% 16700
9 of 51
262 3244 Hydroxyproply Methylcellulose Soln. 108500
263 3245 Neomycin Sulphate, Polymyxine B Sulphate, Bacitracon Zinc
Powder 10gm 421200
264 3246 Artemether&Lumifantrine Pediatric Syrup 15 m 700
265 3315 Syrup Lopinavir + Ritonavir (80/20mg./ml) 160ml per bottle 1000
266 4004 Adhesive Zinc Tape 5cmx10mtr 474000
267 4005 Adhesive Zinc Tape 7.5cmx10mtr 358200
268 4007 Blood Administration Set (ETO) 82200
269 4009 Crepe Bandage Pack (10cmx4mtr) 354000
270 4010 Crepe Bandage Pack (6cmx4mtr) 105500
271 4011 Disposable Hypodermic Needle Size:22x1" 265700
272 4013 Disposable Hypodermic Needle Size:23x1" 404300
273 4015 Disposable Hypodermic Needle Size:24x1" 412900
274 4017 Infusion Set (E.T.O.Sterilised) 2506000
275 4019 Disposable Syringe 10 ml (Without Needle) 1292100
276 4020 Disposable Syringe 2 ml (Without Needle) 1026600
277 4021 Disposable Syringe 5 ml (Without Needle) 1464000
278 4022 Plaster Of Paris Bandage (10cm x 2.7mtr) 239000
279 4023 Plaster Of Paris Bandage (15cm x 2.7mtr) 389700
280 4024 Rolled Bandage (5mt x 5cm) 703200
281 4028 Ab.Surg.Sut.Catgut Plain 2-0 w/o needle 23200
282 4035 Ab.Surg.Sut.Catgut Chromic 1 w/o needle 12800
283 4036 Ab.Surg.Sut.Catgut Chromic 2-0 w/o needle 5000
284 4038 Ab.Surg.Sut.Catgut Chromic 2-0 w/o needle 10300
285 4045 Ab.Sur.Sut.Chromic 2-0 with 1/2Cir.RB30m 47300
286 4047 Ab.Sur.Sut.Chromic 3-0 with 1/2Cir.RB20m 8300
287 4063 Ab.Sur.Sut.Polygly.3-0 with1/2Cir.RB17mm 12200
288 4090 Non-abs.BB.Silksut.on Reel 1 (25mtr) 41900
289 4120 Non-ab. Monofi.Polyamid 3-0 3/8circut16mm 32800
290 4121 Non-ab.Monofi.Polyamid 4-0 3/8circut16mm 14000
291 4179 Absorbent Cotton Wool 400gm 1677000
292 4182 Disposable Needle Size: 26x0.5" 11500
293 4184 Insulin Syringe with Needle) 1ml 40 units 205500
294 4187 I.V Cannula Size 16 G 6700
295 4188 I.V Cannula Size 18 G 126100
296 4189 I.V Cannula Size 20 G 383600
297 4190 I.V Cannula Size 22 G 448700
298 4191 I.V Cannula Size 24 G 345200
299 4198 Elastic Adhesive Bandage Size:10cmX2.70Mtr 617800
300 4227 Foley's Catheter 8 FR (3 to 5 CC Balloon) (Paed) 38700
301 4228 Foley's Catheter 10 FR (3 to 5 CC Balloon) (Paed) 29500
302 4229 Foley's Catheter 12 FR(30 to 50 CC Balloon) 36800
303 4230 Foley's Cath. 14 FR (30 to 50CC Balloon) (2 Way) 125500
304 4231 Foley's Cath. 16 FR (30 to 50CC Balloon) (2 Way) 223100
305 4232 Foley's Cath. 18FR (30 to 50CC Balloon) (2 Way) 79300
306 4269 Disposable Syringe 20 ml 86500
307 4270 Disposable Syringe 50 ml 116300
308 4275 Disposable Spinal Needle (Size: 22G) 8200
10 of 51
309 4278 Disposable Spinal Needle (Size: 23G) 152000
310 4305 Micropore Adhesive paper Tape 71800
Note: For detailed specification refer to Schedule to STANDARD, COMPOSITION,
PACKING ,EMD, MINIMUM BATCH SIZE, WHO GMP, PACKING PER CARTON,
APPROX TWO YEARS REQUIREMENT.
11 of 51
Instruction to Bidders for Online Tender Participation
1-All tender documents can be downloaded free from the website https://gmscl.nprocure.com
2-All bids should be submitted online from the website https://gmscl.nprocure.com
3-All bids should be digitally signed, for details regarding digital signature certificate and related
training involved the below mentioned address should be contacted
(n) Code solutions (A divisionof GNFC) 301, GNFC Infotower, Bodakdev,Ahmedabad
Ahmedabad-380 054 ( India ) Tel : +91 79 26857316/17/18
Fax: +91 79 26857321. www.ncodesolutions.com
4-The user can get a copy of instructions to online participation from the website
https://gmscl.nprocure.com.
5. The suppliers should register on the website though the “New Supplier” link provided at the
home page the registration on the site should not be taken as registration or empanelment
or any other form ofregistration with the tendering authority.
6-The application for training and issue of digital signature certificates should be made at least 72 hours in advance to the due date and time of tender submission.
7-For all queries regarding use of digital signature certificate should be addressed to personnel in M/s (n) Code Solutions.
(8).A-Group documents should be submitted online only and B-Group documents should
be submitted physical only as per Annexure-X.
8-For all queries regarding tender specifications and any other clauses included in tender document should be addressed to personnel in tendering office address provided below
Contact Details: Managing Director
Gujarat Medical Services Corporation Limited Regd. Office: Block No.14/1, Dr. Jivraj Mehta Bhavan, Sector-10, Gandhinagar. Tel: 079-23250770, 23250766 ,Fax: 079-23257586
Key Dates: Due Date and Time of Submission of
TechnicalBid&Commercial Bid. (online)
: 07 /05 /2018 Up to 16.00 Hrs.
Due Date and Time of PhysicalSubmission of
TechnicalSupporting Documents inclusive of Document
Fee& EMD
: 08 / 05 /2018 Up to 16.00 Hrs.
Due Date and Time of TechnicalBidOpening (online) : 09 /05 /2018 At 15.00 Hrs.
Envelopes containing the “Technical Supporting Documents”, inclusive of the “Document Fee”,
“EMD Fee” tobe submitted at the below mentioned address. Venue: Managing Director
Gujarat Medical Services Corporation Limited Regd. Office: Block No.14/1, Dr. Jivraj Mehta Bhavan, Sector-10, Gandhinagar. Tel: 079-23250770, 23250766 Fax: 079-23257586Key Value: Document Fee: -
EMD:-
12 of 51
A. GENERAL INSTRUCTIONS FOR BIDDERS
The bidders are instructed to read the complete bid document carefully. The following points
may be noted so that mistakes/lapses/shortcomings during Bid submission may be avoided.
1. It is expected from all bidders that they will ensure that documents to be used in bid set will be
given to a reliable person only. So that the confidentiality of your bid/ rates is maintained up to
bid opening & that your documents are not put to any misuse.
2. Complaints lodged in GMSCL should bear signature, name, Id proof and mobile number
of the complainant. This is important to avoid unauthenticated complaints or any persons who
have fraudulently made use of their letter heads. Therefore, unauthenticated complaints may
not be acted upon.
3. In case you are given any assurance of any favour in GMSCL, by anybody or if you are
directly or indirectly threatened or i n t i m i d a t e d of harming your bidding & subsequent
work in GMSCL, please inform immediately about the same to MD, GMSCL. It would be
better if evidence of such unfair activity of such person is produced so that action can be taken
against such person / institution and their details can be put on the website.
4. It is advisable for you to authorize only those persons for GMSCL tender who are
employed in your company on salary basis.
5. If any firm, etc. intends to lodge a complaint against a bidder with regard to bid (bid
Condition), it may do so within 21 days of opening of technical bid, in the office of GMSCL.
After the stipulated period, it will not be possible to act upon the complaint.
6. The turnover should be as per bid conditions. Do not submit Bid if the turnover of the firm is
less.
7. Quote only for the products for which your Product Permission meets the Bid specifications.
Do not quote if it differs with regard to any parameter.
8. Quote rate exactly as per packing unit of tender schedule. For example if the packing is
given for 10x10 tablets, the rate should be quoted for 10x10 tablets, and not for 1 tablet or
10 tablets.
9. Highlight the quoted items in the documents like Product Permission and Market
Standing Certificate, and also mark the item code no. at appropriate place in the documents.
10. The submitted product permission and other documents should be authentic. Date of issue of
the documents should be clearly visible.
12. In case there is any suggestion regarding Bid conditions/ specifications/ shelf life, strength,
packing/turn over etc. The suggestions should be submitted/sent/e – Mailed two/three days
earlier from the date of pre bid meeting so that the representation of the bidders may be well
processed and decision could be taken well in time.
13. No tender will be accepted after prescribed closing time for submission of the same. The
delay will not be condoned for any reason whatsoever including postal/transit delay. However,
if the last date of submission of tenders is declared as a holiday by the Government, the last
date of submission of tenders will be extended to the next working day.
14. The tenderer should confirm that the detailed specifications i.e. standard, composition, packing,
minimum batch size, WHOGMP of the items offered are strictly in accordance with the
specifications shown in the Schedule (Schedule of tender). The tenderer must also mention
the name of manufacturer in case of direct importers in Technical & Commercial. The
tenderer should also note the terms & conditions particularly those relating to the delivery
period, E.M.D., Marketing Data & Proof of Manufacturing Experience, Minimum batch size,
Payment terms, Penalty, Pre-dispatch sample testing, Rate Contract, replacement and Risk
purchase in which no relaxation will be given.
13 of 51
15. The tenders will be opened on the date, time & venue specified in tender notice and the
tenderer or his authorized agent has the liberty to be present at that time. However, in
unavoidable circumstances, the Managing Director can change the date / time / venue of
opening or open the tenders in the absence of tenderers or his agent at his discretion. In
case the specified date is declared as holiday by the Government, the tenders will be opened on
the next working day at the same time and venue specified in the tender.
16. If there is any query regarding Terms and condition in Bid document, you may contact
General Manager (LPQC), GMSCL
DGM(Drug Procurement), GMSCL
Manager (Drug Procurement), GMSCL
17. If any tenderer wishes to lodge any complaint against the other tenderer regarding submission
of false documents, information etc., The tenderer has to submit the complaint before price bid
opening along with deposit of Rs. 1,00,000 (Rupees One Lac only). The amount so deposited
shall be refunded if after scrutiny the complaint is found to be true by the Managing Director.
However, if the complaint is found to be false and malafide the deposit will be forfeited. No
interest shall be paid against this deposit. Any complaint received after price bid opening will
not be entertained. The facts relating to all such complaints as well as action taken thereof have
to be produced before the respective purchase committee for its consideration.
B. ELIGIBILITY CRITERIA
1. Bidder shall be a manufacturer having valid manufacturing license or direct importer
holding valid import license. Distributors/ Suppliers / Agents are not eligible to participate in
the Bids.
2. If manufacturer is not available for imported Drugs/ Surgicals /Diagnostic Kit, then
authorized representative or dealer shall be allowed to quote the tender. But such authorized
representative or dealer should be regular supplier of quoted product of that manufacturer for
preceding two years from the date of opening of technical bid and authority letter (As per
format Annexure VIII) & valid import license (where ever applicable) should be submitted
along with tender.
3. Must have minimum three years of experience as a manufacturer and in marketing of the quoted
item, as on the date of technical bid opening. The Bidder Should also have manufactured at
least 3 three commertial batches of the quoted drug every year in the last 3 consecutive years
(Annexure II). In case of imported product, the product should have minimum 3 years standing
in the market. The importer should have at least 3 years standing as manufacturer/ importer of
drugs in general. Imported drugs shall be accepted in brand name also.
4. (a)The Average Annual turnover of last three years should not be less than 2
crores.
(b) For SSI units of Gujarat the average annual turnover should not be less than Rs.75.00
lacs for list of items attached at annexure.( Annexure-XIII)
c)The Manufacturer should have valid WHOGMP Certificate or valid Certificate of
pharmaceutical product (COPP) for individual product in the WHO format. Unless the date of
expiry is specially mentioned in the certificate,the validity of WHOGMP (COPP) certificate will
be considered as two years from the date of issue, effect for foreign product where the tenders
most affirm the date of validity. No offer will be acceptable unless the tender is accompanied by
requisite WHOGMP describe above.Manufacturers not having valid WHOGMP certificate are
not entitled to submit tender.Under no circumstances submission of copies of renewal
application / challan for expired WHOGMP certificate will be considered in lieu of valid
WHOGMP certificate. Conditional WHOGMP will not be accepted..
(d) The Certificate mentioned above must include either the name of drugs or the category of
drugs for which the WHOGMP is issued. In case of imported Drugs/Surgicals/DiagnosticKit,
14 of 51
valid Drug ManufacturingLicense, ProductPermission, WHOGMP certificate of manufacturer,
Labels and Product literature of all quoted product must be submitted along with the tender.
5. In case, where the item is required with ISI Mark, manufacturing and selling experience of
product having ISI Mark is mandatory for eligibility. Hence the manufacturer must have valid
certificate copies of license to use ISI for last one year and the latest license should be valid
during the period of Rate Contact.
6. The SSI must have , a valid Micro/ Small enterprise registration ( As per Gazette of India Act-
2006) issued by concerned authority of Gujarat state along with valid certificate of CSPO/
NSIC/DGS & D/ KVIC Registration.
7. Bid should not be submitted for the product/products for which the
concern/company stands blacklisted/banned/debarred either by Bid inviting Authority or Govt.
of Gujarat or its departments on any ground. The Bid should not be submitted for those
products also for which the concern/company stands blacklisted/banned/debarred by any other
State/Central Govt. or it‟s any agencies (central Drugs procurement agencies) on the ground of
conviction by court of law or the products being found spurious or adulterated.
8. Such concern/company/firm which stand blacklisted/banned/debarred on any ground by the bid
inviting authority (GMSCL) or Govt. of Gujarat or its department on the date of bid submission,
shall not be eligible to participate in the bid. The concern/company/firm
which stands blacklisted/banned/debarred on the ground of conviction by court of law or the
products being found spurious or adulterated by any other State /Central Government or it‟s any
agencies (central Drugs procurement agencies) shall also not be eligible to participate in the
Bid. For Specific cases regarding other quality issues the respective purchase committee of
GMSCL may decide on case to case basis.
The concerned company/firm/bidder who has been blacklisted / debarred by GMSCL or any
other State/ Central Government and its Drug Procurement Agencies due to failure in supply
of Quality drugs, shall not participate in the tender during the period of debarring / blacklisting.
If any product of company/firm/bidder were blacklisted/debarred at the time of bidding, for a
specified period, then the same will become eligible after blacklisting/ debarring period is over.
In case the period is not specified the debarment order, the firm shall be eligible to participate
in bidding only after two years of the date of issue of the order of blacklisting/ debarment. If
any tenderer is debarred or black listed due to failure in supply of Quality Drug during the
tender validity or during the validity of the rate contract by any other State and central
Government and its Drug Procurement Agencies, it is his (tenderer‟s) responsibility to inform
such thing to the Managing Director, GMSCL.
9. Non-Disclosure of blacklisting/ debarment will invite forfeiture/recovery of EMD or SD or
Risk Purchase or disqualification for appropriate period or any other penal action at the
discretion of Managing Director, GMSCL without any further reference. (As per format
Annexure-IX)
10. The concern/firm/company whose product has been declared as of spurious or adulterated
quality and any criminal case is filed and pending in any court shall not be eligible to
participate for that particular product, in the Bid. Similarly convicted firm/company shall also
not be eligible to participate in the Bid.
11. If a company has two or more separate manufacturing units at different sites/states,
the company will be allowed to submit only one Bid for all units but necessary document
regarding separate manufacturing units will be submitted as a separate set with the same Bid.
But a bidder will be allowed to submit only one offer for one product.
15 of 51
C. TECHNICAL BID
1. The technical bid submission should be done on the following website only
https://GMSCL.nprocure.com
2. The “Technical Supporting Documents” of Tender inclusive of the “Document Fee”, “EMD”
should be submitted at the below mentioned address:-
Managing Director
Gujarat Medical Services Corporation Limited
Regd. Office: Block No.14/1,
Dr. Jivraj Mehta Bhavan, Sector-10, Gandhinagar.
Tel: 079-23250770, 23250766
Fax: 079-23257586
3. If the supplier fails to submit the supporting documents offline on or before the due date and
time of physical submission of tender supporting documents inclusive of Documents Fee and
EMD, the bidder is entitled for immediate disqualification.
4. The tenderer should invariably submit his tender in three sealed covers separately namely [1]
Document Fee Cover, [2] E.M.D. Cover [3] Technical Supporting Documents Cover. The
details of these documents to be submitted are as mentioned below in the respective heads:-
5. DOCUMENT FEE COVER
a) Payment as document fee should be made by DD o n l y , p a yab l e a t G an d h i n aga r
a t an y S ch ed u l ed b an k / n a t i o n a l i z ed ban k , i n f av o r o f G u j a r a t M ed i ca l
S e r v i ce s C o r p o r a t i o n Li m i t ed , G an d h i n aga r
b) Payment made toward document fee will not be refunded.
c) Non-payment of the document fee will make the tenderer liable for disqualifications.
d) The tenderers who are desirous of availing SSI benefits shall have to submit a letter
clarifying that they want to avail the benefits and must adhere to guidelines as mentioned
in Point (a) of General Terms & Condition ( Heading D)
6. EMD COVER
a) The E.M.D. should be paid in form of Treasury Chalan deposit under Revenue Deposit or
by Demand Draft in favour of G.M.S.C.L., Gandhinagar drawn on any bank in Gandhinagar
or irrevocable Bank Guarantee stamped with adhesive stamp of Rs.100/- issued by Schedule
Bank. The Demand Draft should be issued by bank only after date of advertisement of
tender enquiry. The Bank Guarantee will be accepted in case where the amount of E.M.D.
exceeds Rs.5000/- and such Bank Guarantee should be valid up to six month from the date
of its issuance. E.M.D. in any other forms will not be accepted. The bank guarantee for
EMD will be accepted as per government resolution of finance department.
b) Non- payment of the EMD will make the tenderer liable for disqualifications.
c) Wrong/ Fraudulent data submission may lead to disqualification / debarment. Please
ensure that you furnish correct data.
7. TENDER SUPPORTING DOCUMENT COVER:-
Please refer to General Terms and Conditions and Check List of Tender as in Annexure-X
A-Group documents should be submitted online only and B-Group documents should
be submitted physical only as per Annexure-X.
16 of 51
D. GENERAL TERMS AND CONDITIONS OF TENDER:-
1. Special Benefits for Small Scale Industries:-
Those tenderers who are desirous of availing the benefits as provided for SSI
units by Government vide GR No. SPO/102015/691093/CH dated: 03/06/2016 issued
by Industries & Mines Department:-
a) Exemption for Payment of document fee, exemption for Payment of EMD & Benefit
of Security deposit. Shall have to submit, valid Micro/small enterprise registration in
new acknowledgement (As per the Gazette of India Act-2006) issued by concerned
authority of Gujarat state along with valid certificate of CSPO / NSIC / DGS & D/KVIC (if
applicable) registration.
b) To avail the benefit of Price Preference & Price matching,
(1) Tenderers Shall have to submit a valid Micro/small enterprise registration certificate (As
per the Gazette of India Act-2006) issued by concerned authority of Gujarat state
(2) valid certificate of CSPO / NSIC / DGS & D/KVIC (if applicable) registration .
(3) Self-attested copy of Certificate from Practicing Chartered Accountant or Practicing company
Secretary that the unit / bidder still continues to be Small Scale, Tiny/ Cottage Industry should be
asked as under :
(i) MSME status for the year before the immediate previous financial year if the tenders are issued
on or before 30th September.
(ii) MSME status for the immediate previous financial year if the tenders issued on or after 30th
September.
(4) Self-attested copy of latest audited annual balance sheet and investment in plant and machinery to be
certified by the same professional.
(5) Certificate / documents mentioned in above (b) (3 & 4) should be from same professional.
C) Price preference will be calculated as per guidelines given by the Govt. of Gujarat,
Industries and Mines Dept., resolution GR No. SPO/102008/794/CH, dated 02/09/2015
(d)Main/ Parallel/ Substitute Rate Contract for procurement of stores will be fixed up as per G.R.
No. MSP/102002/3342/JH, dated 06/11/2003& dated. 04/10/2006.
2. Marketing Data & Proof of Manufacturing Experience:-
a) All the manufacturers for quoted items must have minimum preceding three years‟
experience for manufacture (after issuance of permission by concerned licensing
authority) & marketing of the quoted products on the date of opening of technical bid.
b) However, for manufacturer having preceding one year manufacturing & marketing
experience under valid license to use ISI mark for the quoted product on the date of opening
of technical bid will also be considered.
c) If the tender is scheduled to open on 01-01-2008, the three years manufacturing
experience is considered only if the first batch of quoted item is manufactured on 01-01-
2005 or earlier to that date and should have continuous production till the date of
opening of technical bid. The date of manufacture of first batch & its quantity must be
clearly shown in the second column of affidavit which must be strictly in accordance with
the performa shown in Annexure-II.
d) In case where tender is to be submitted by authorized representative/dealer for imported
drugs/surgical /diagnostic kit should be a regular supplier of a quoted product of that
manufacturer for preceding two years from the date of opening of technical bid and first
date of imported quantity and year wise imported quantity and sale in India of that item duly
supported by affidavit from importer. The report should be submitted as per Annexure-II.
e) Discontinuance of production of quoted item after a single batch or no production
thereafter will be considered as insufficient experience & the product will be disqualified.
The manufacturer must therefore submit manufacturing data separately & year wise for at
17 of 51
least preceding three years/two years/ one year (whichever is applicable) with distinct
quantity & value & number of batches strictly in the said format (Annexure-II).
f) Managing Director reserves the right to disqualify any offer if the total manufactured
quantity shown in the affidavit is apparently insufficient in relation to the approximate
purchases of last R.C.
g) The year wise quantity manufactured / imported and marketed & its sales value must also be
shown strictly as per the format in affidavit. ( Annexure-II). Details Data in Letter head of
Company is not acceptable. It must be given in affidavit duly done by a public Notary.
h) In case where item is required with ISI Mark, manufacturing and selling experience of
product having ISI mark will only be considered. But, in such a case, certified copies of
license to use ISI mark for last one year as well as latest and valid license are to be submitted
with tender. The latest license should be valid during the period of rate contract.
i) In addition to affidavit for production / import and sales, the tenderer has to furnish C.A.
Certificate (in original/Notorized) showing year wise production / import & sales for last
three years/two years/one year (whichever is applicable) for the item quoted,
otherwise offer will be rejected.
j) Authorization letter nominating a senior responsible officer of the company with authority
to transact business also to be provided with tender.
3. Turnover Criteria
(a) Bidder firm has to submit turnover certificate of chartered Accountant for last three years. [i.e. (i) 2014-15, 2015-16, 2016-17 for tender floated on or after 30th September, 2017 The Average Annual turnover of last three years should not be less than 2 crores.
(b) For SSI units of Gujarat the average annual turnover should not be less than Rs.75.00 lacs
for list of items attached at annexure.( Annexure-XIII)
(c) VAT Clearance Certificate (Last Financial Year) / Certified copy of VAT Return
Mentioning Zero Outstanding (Last Financial Year).
(d) No conditional offer / quotation will be accepted. No variation in the terms and conditions
of the tender, including deviation from standards / specifications / terms of supply will be
accepted.
4. Technical Supporting Documents for Tenders
The legible and certified copies of the following documents must be attached /annexed to
Technical Supporting Documents:-
a ) Valid Manufacturing license & Product Permission (as the case may be) for imported
products valid Manufacturing License& Product Permission of
manufacturer (as the case may be).
b) Valid Appropriate Drug License of tenderer & Valid Import License for imported Products.
c) Valid Narcotics / Explosives License. (if applicable).
d) Valid WHOGMP certificate of manufacturer.
e) (1) Micro/small enterprise Registration certificate and valid CSPO/N.S.I.C./D.G.S. &
D/K.V.I..C. (if applicable), Pl. see Condition No.4.
(2) Certified / Notarized copy of latest audited annual balance sheet and information providing their
Investment in plant and machinery to prove their present status as an SSI Unit.
f) I.S.O. certificate along with the declaration of manufacturer of the item in the location
certified by I.S.O. in the prescribed format (if applicable).
g) Valid I.S.I. certificate (if applicable)
h) Photo copy of PAN card (Permanent Account Number)
i) Prescribed affidavit showing year wise production / import & sales for preceding three years/
two years / one year (as the case may be) for items quoted in original. (As per format
18 of 51
Annexure-II)
j) Higher price / Lower price certificate. (As per format Annexure-III).
k) Non-conviction certificate (Certificate Issued within 12 months before due date of this
tender) issued by concerned Food & Drug control Authority. (Preferably as per format
Annexure-XII).
l) VAT Clearance Certificate (Last Financial Year) / Certified copy of VAT Return
Mentioning Zero Outstanding (Last Financial Year).
m) Affidavit regarding format of certificates. (As per format Annexure-IV).
n) Performance Certificate.(Certificate Issued within 12 months before due date of this tender).
from concerned Food & drug control Authority.(Preferably as per format Annexure-XI).
o) C.A. Certificate in original/ Notarized showing year wise production / import& Sales of
quoted items for preceding three years/two years/one year (whichever is applicable).
p) C.A. Certificate in original/Notarized showing year wise Turnover for last three
years[i.e. (i) 2014-15, 2015-16, 2016-17 for tender floated on or after 30th September, 2017
Authority letter in prescribed format for imported items. (As per format Annexure-VIII).
q) Verification, Undertaking checklist & Document. (As per format Annexure-I)
(ON STAMP PAPER OF Rs.20.00 & TO BE NOTARIZED)
r) Statement of capacity of production. (As per format Annexure-VII).
s) Declaration about debarment of manufacturer for the items quoted. (As Per format-
Annexure-IX)
t) Sales Tax (VAT) / CST/ Goods and Service Tax (GST) registration copy.
u) (ALL PHOTOCOPIES ARE REQUIRED IN SELF ATTESTATION
MODE EXCEPT AFFIDAVIT IN ORIGINAL ON NON JUDICIAL
STAMP PAPER DULY ATTESTED BY FIRST CLASS
MAGISTRATE/NOATARY PUBLIC) Before submission of any tender, the
tenderer must verify that they have submitted all relevant certificates / permissions /
documents in proper format along with tender. No intimation of missing documents
will be given by this office. No documents will be accepted thereafter and the
tenders will be processed on the basis of available documents / certificates. If the
requisite documents are not submitted or even if submitted are not in proper format, the
tender is liable to be rejected.
5. All documents specified must strictly be as per the format wherever the format is
prescribed in tender Document or as prescribed by concerned authority viz. FDCA, ISI,
Commercial Tax etc. and must be valid on the date of opening of tender. The documents of
drug license, C.S.P.O. registration, higher price / lower price certificate, non-conviction
certificate, Commercial Tax Clearance Certificate are to be furnished with tender. Moreover
proof of application for renewal or Challan thereof for above certificates will not be
considered in lieu of valid certificate except in case of renewal of Drug Licence.
6. The tenderer must satisfy that they are in possession of the requisite permissions / licenses /
permits required for the manufacture / supply / sale / distribution of the items as per the
specifications for which the offer is made. Failure to enter into contract if selected or to
execute the purchase orders after entering into contract for want of permission / license or due
to non-supply of certificates / documents will be viewed seriously and will invite forfeiture of
E.M.D. / risk purchase / disqualification for appropriate period without any further
reference.
7. The E.M.D. / Security Deposit shall liable to be forfeited in the following circumstances when the:
a) Tender is rejected due to failure to furnish the requisite documents in the proper format or
giving any misleading statement or submission of false affidavit or fabricated documents.
19 of 51
b) Party fails to sign the agreement for entering into contract in case the offer is accepted,
due to any reason whatsoever.
c) Party fails to supply the goods / items as per the orders placed by either this GMSCL
or by Direct Demanding Officers (DDOs) within the delivery period so stipulated;
d) Party fails to replace the goods declared to be not of standard quality or not
conforming to acceptable standards or found to be decayed / infected / spoiled before the
date of expiry have to refund the cost of such goods.
8. The claim of price revision of finished goods under any pretext or reason, including the
revision of duty / excise / cost will not be allowed at any stage after the last date of submission
of the tenders.
9. The period of the rate contract shall be approximately two years from the date of issuance of
Rate Contract. However, the Managing Director reserves the right to terminate the contract by
giving one-month notice at any time at any stage and without any reason. The rate contract will
be operated by GMSCL only. If a RC holder supplying goods upon direct purchase order from
district level officer without approval of GMSCL, it would be considered as a breach of
contractual obligation and would attract penal action which may extend up to debarment of
firm.
10. The Managing Director may extend the rate contract, subject to the same terms and
conditions. If found necessary to do so for a period not exceeding six months to which the
contractor will have to abide. However, the extension for a period more than six months can
be granted on mutual agreement by both parties.
11. Periodical Statement of Supply:-The Rate contract holder shall have to submit a quarterly
(Every three months) report of supply made to the Direct Demanding Officers and others
(Other than GMSCL).In the said report RC holder shall have to furnish the Name of institution
,Item code, Name of item, Order No &Date, Order Qty & Amount, Date of supply and supplied
qty. etc to this office. It is mandatory to provide this information to GMSCL as an integral part of
RC.
12. Whenever under this contract any sum of money is recoverable from the contractor &
payable by the contractor to the Managing Director of Gujarat Medical Services Corporation
Limited, Gandhinagar or an officer empowered by him shall be entitled to recover such sum by
appropriating in part of whole the Security Deposit paid by the Contractor, if a security being
insufficient or if no security has been taken from contractor, then the balance of the total sum
recoverable as the case may be deducted from the sum due to the contractor under this or any
other contract (with the Managing Director of Gujarat Medical Services Corporation Limited,
Gandhinagar) and remaining balance due will be recovered as arrears of „Land Revenue Dues‟.
13. The tenderer should submit statement of capacity of production as per Annexure-VII.
14. For any clarification on any of the above conditions, tenderers may contact the officers
during 3 p.m. – 4 p.m. on any working day. They may also meet the Managing Director/
Manager Procurement/DGM(Drugs) with the prior appointment.
15. Documentary evidence for the constitution of the firm such as memorandum and articles of
association, partnership deed etc. with details of name, address, telephone / fax no, e-mail
address of the firm and of the Managing Director/ Partners / Proprietor to be provided with the
tender.
16. For all items which covered under the definition of Drugs & for all procedures of tender&
finalizing the tender, the provision of Drugs &Cosmetics Act, 1940 & Rules there under
shall be applicable& considered final.
20 of 51
17. Quantity shown in column No.11 of Schedule is approx. tentative requirement of the item. It
may increase or decrease. The rates should not vary with the quantum of requirement. The
tenderer must supply the quantity as ordered by Direct Demanding Officers or by this
Corporation during the period of Rate Contract.
18. The minimum batch size of which the delivery will be accepted as shown in the Schedule. In
case, the aggregate of all the orders for which a particular batch is manufactured is less than the
minimum batch size prescribed in Schedule, the minimum batch shall be limited to the
aggregate of all the orders.
E. COMMERCIAL BID
1. The commercial bid submission should be done on the website only
https://GMSCL.nprocure.com
2. The bids should be submitted on or before the time stipulated in tender notice at the website
https://GMSCL.nprocure.com
3. The quoted rates should be valid for S I X months from the date of opening of technical bid. Rates
once quoted will be final and will not be allowed to be increased during the validity period
under any circumstances and for any reason whatsoever.
4. The rates quoted should be F.O.R. destination anywhere in Gujarat basis irrespective of
value of order and inclusive of all charges such as packing, delivery, insurance, inspection, etc.,
per unit of packing as shown in the enquiry document. The rates shown against the item
shall be presumed, in all cases, as the net price inclusive of all duties and sundries. No payment
against any duties / delivery charges etc. will be considered under any separate heading
under any circumstances Tenderer will also have to guarantee for regular and timely supply of
all the items.
5. For out state tenderer they can supply from Gujarat Depot provided they submit the following
documents along with the tender.
(i) Valid wholesale Drug License.
(ii) Gujarat sales Tax (VAT) registration certificate & clearance certificate.
(iii) Undertaking from where the supplies is made.
6. In no case, rates should be quoted anywhere except in Commercial Bid part. The tender will be
summarily rejected without any further processing or reference if the rates are quoted or
written at any place except at the relevant place in Commercial Bid part. In no case, rates for
any item should be quoted in Commercial Bid part for which the technical details are not given
or the items not quoted with details.
F. OPENING OF TECHNICAL AND COMMERCIAL BID
1. In the first instance only the "Technical Bid" (online) & envelope containing Technical
supporting documents will be opened by any two officers from GMSCL, Gandhinagar on the
date of opening of the tender and taken into consideration for finalization.
2. Scrutiny of the Tenders will be done as per terms & conditions of the tender, Govt.
Resolutions issued from time to time and guidelines given in the manual of office procedure
for purchase of stores by the Govt. Departments issued by Industries & Mines Dept.
Govt. of Gujarat.
3. Scrutiny of the Tenders will be done by GMSCL with support of technical evaluation
committee formed by the Board of GMSCL for the purpose. Inspection of manufacturing unit
for compliance of WHOGMP may be carried out by technical committee if needed.
21 of 51
4. The tender is liable for rejection due to any of the reasons mentioned below:
a) Non-submission of tender within stipulated time.
b) Submission of tender without Tender document fee.
c) Tender supporting document not submitted in separate envelopes as per conditions and
the envelopes are not super scribed with details of the tender enquiry and part enclosed.
d) Non-payment of Earnest Money Deposit (if not exempted).
e) Non-submission of required documents as shown in general condition and Annexure-X.
f) Conditional offers. Conditional and / or vague offers.
g) Unsatisfactory past performance of the tenderer.
h) Rates have been shown elsewhere than Commercial Bid part.
i) Items with changes / deviations in the specifications / standard / grade / packing /quality.
j) Rates are quoted in technical bid.
k) Stamp paper is not as per statutory provisions.
l) Submission of misleading / contradictory / false statement or information and
fabricated / invalid documents.
m) Tender not filled up properly as mentioned in the tender document.
n) Non-submission of authority letter in prescribed format for imported items.
o) Non submission of Micro/small enterprise Registration certificate and valid
CSPO/N.S.I.C./D.G.S. & D/K.V.I..C. (if applicable). Please see Condition Point (a) of
General terms and Conditions.
p) Non- Submission of Certified / Notarized copy of latest audited annual balance sheet and
information providing their Investment in plant and machinery to prove their present
status as an SSI Unit.
5. Subsequently, the "Commercial Bid" (online) will be opened only of those tenderers
whose Technical Bid satisfy the technical requirements of the tender and are otherwise
acceptable. The "Commercial Bid" (online) will be opened by any two officers from
GMSCL, Gandhinagar.
6. Back out from tender at any interim level during tender processing:-
Once the tender is submitted it will be the responsibility of the tenderer not to escape half
way directly or indirectly by way of raising any problems: In case of back out from the tender
process, penal action may be taken as decided by the board of GMSCL.
7. Bid Inviting Authority reserves the right to accept or reject the Bid for the supply of all or any
one or more items of the drugs bided for in a bid without assigning any reason.
8. Bid Inviting Authority, or his authorized representative (s) has the right to inspect the factories
of Bidders, before, accepting the rate quoted by them, or before releasing any purchase
order(s), or at any point of time during the continuance of Bid and also has the right to reject
the Bid or terminate/cancel the purchase orders issued and or not to reorder, based on
adverse reports brought out during such inspections.
G. ACCEPTANCE OF BID
1. The acceptance of the Bids will be communicated to the successful Bidders in writing (e-
mail/Letter) by the Bid inviting authority.
2. Immediately after receipt of acceptance letter, the successful Bidder will be required to submit
Security Deposit and agreement should be within 10days.
H. SECURITY DEPOSIT
1. Successful tenderers have to pay security deposit as specified by the Corporation in the
22 of 51
agreement letter in the form of treasury challan deposit under revenue deposit /
Demand Draft in the name of Gujarat Medical Services Corporation Limited, Gandhinagar
drawn on any bank in Gandhinagar / irrevocable bank guarantee stamped with adhesive of
Rs. 100/- valid for a period not less than 36 months at the time of entering into agreement for
the performance of the contract.
2. Failure to pay security deposit and to execute the agreement within stipulated period shall
invite disqualification of the tenderer for future quotations apart from forfeiture of E.M.D.
and being liable for penalty as deemed fit by Managing Director in relation to the tender
under process. Security deposit is payable by all the parties except by the undertakings and
corporations of the Government of Gujarat which exempted by Govt.
3. The security deposits submitted in connection with the earlier contract and which are locked
with those contracts and which have not been released till date will not be considered and fresh
security deposit separately for each item must be submitted in such cases.
4. The security deposit shall be refunded only after satisfactory execution of the contract
and recovery of dues, if any.
I. AGREEMENT
1. Successful tenderers have to enter into agreement within 10 days for due performance of the
contract. The agreement form sent by this Office should be stamped with adhesive stamp
for the requisite amount, and signed before any Gazetted Officer of this Office or before a
Ist class Magistrate or Justice of peace or Notary Public.
2. The accepted tender (AT) holder / rate contract (RC) holder should supply the items as per
specifications and packing approved by GMSCL. Otherwise the stores will not be accepted
and penal action will be taken against the AT/RC Holder.
3. All supply orders issued by the indenting offices issued on or before the last date of the
contract of the RC will have to be accepted by the RC holder and the delivery for all such
orders will have to be effected as per the schedule specified in the order, even though the date
of actual supply may fall beyond the last date of the RC.
4. The AT/RC Holder must supply the drugs and other items of stores as per the standards of
quality mentioned in second schedule of Drugs &Cosmetics Act, 1940 & respective
pharmacopoeia. The stores must continue to confirm to the usual pharmacopoeia limits of
potency, if tested at any time during its shelf life till its expiry date.
J. SUPPLY CONDITION
1. Purchase orders along with the delivery destinations will be placed on the successful Bidder at
the discretion of the Ordering Authority. Drugs and Medicines will be supplied at any place
across the State as mentioned in the Purchase Order.
2. The Tenderer must submit a test analysis report from a NABL laboratory/ Govt. approved
(FDCA Approved) public testing laboratory for every batch of drug along with consignment.
However, if the tenderer submits a report from GLP compliant in-house testing
laboratory, the supplies would be accepted subject to a reduction of two weeks in the
permissible delivery period from that mentioned in point (c) below.
3. Delivery Period: Unless specified in the tender or instructed by the managing Director, the
maximum delivery period shall be eight weeks for all the items, except for all injectable item
and sterile category items delivery period will be ten weeks However, the Managing Director
may extend the delivery period in slabs of two weeks up to maximum of 12 weeks for orders of
23 of 51
large quantity.
4. For this purpose, the extension in delivery period shall be given as per the prevailing policy
framed by Managing Director, GMSCL or the Concerned Purchase Order committee. The
maximum delivery period will be counted from the next working day after the actual date of
posting the order provided that the Managing Director, may at his discretion, may procure
20% of the order immediately and balance quantity of the order within 4 weeks to meet
any situation of exigency / epidemic / calamity.
5. Risk Purchase:- The risk purchase of the items ordered at the cost and risk of the party will
be carried out when the party fails to:
a) Sign the agreement for entering into contract due to any reason whatsoever in case the offer
is accepted.
b) Supply the goods / items as per the order placed by either this corporation or by direct
demanding officers in accordance with the main / parallel / substitute rate contracts, either
during the prime / extended validity period or within the delivery period stipulated above.
c) The Risk Purchase will be done at any time after the delivery period is over.
d) The Risk Purchase will be done from Main / Parallel or Substitute R.C. holder for
undelivered quantity of the Stores & the Contractor shall be penalized to the extent of
10% or difference whichever is higher.
6. GMSCL would also place direct supply order to other organizations/ CPSEs as per govt. norms
in case:-
a) Tenders/ offers are not received or
b) Tenders are not finalized due to any reason or
c) RC holder supplier fails to supply the required / ordered quantity or
d) In case of Emergency or Epidemics.
In aforesaid circumstances quotations will be invited from all the CPSEs and placed before
concerned procurement committee for decision.
7. Under such circumstances difference will be recovered from the concerned RC holder who
failed to supply.
8. The order stands cancelled after the expiration of delivery period, and if the extension
is not granted with or without liquidated damages.
9. It shall be the responsibility of the supplier for any shortage/ damage/ breakages at the
time of receipt at the designated places.
10. If at any time the Bidder has, in the opinion of the ordering authority, delayed in making
any supply by reasons of any riots, mutinies, wars, fire. Storm, tempest or other exceptional
cause on a specific request made by the Bidder within 7 days from the date of such
incident, the time for making supply may be extended by the MD, GMSCL at his discretion
for such period as may be considered reasonable. The exceptional causes do not include
the scarcity of raw material, Power cut, Labour disputes.
11. The supplier shall not be in any way interested in or concerned directly or
indirectly with, any of the officers, subordinates or servants of the Bid Inviting Authority
in any trade or business or transactions nor shall the supplier give or pay promise to give
or pay any such officers, subordinates or servants directly or indirectly any money or fee or
other considerations under designation of “Customs” or otherwise, nor shall the supplier
permit any person or persons whom so ever to interfere in the management or
performance hereof under the power of attorney or otherwise without the prior consent in
writing of the Bidder Inviting Authority.
24 of 51
12. In case of item having pharmacopeial Standard the brand name of item or abbreviations
indicating the same can be printed anywhere on both internal / external packing. However
the font size of such brand name or abbreviation printed on internal / external packing
should not be more than 50% as compared to the generic name. The supplier would have
to produce an undertaking regarding the same at any time prior to make the supply.
13. The RC holder shall have to supply the drugs with different color, coding, packing,
labelling as well as display of rates on packaging as and when required by GMSCL.
14. Notwithstanding various action and penalties for non-supply and / or delayed supply of the
Drugs. GMSCL shall take action against the supplier as follows:
a) If the supplier fails to execute at least 70% of the ordered quantity as mentioned in a
single Purchase order and such part supply for any three Purchase orders of the same
drug, then the product of the supplier will be debarred and becomes ineligible to
participate in any of the tenders for that particular item(s) by GMSCL for a period of 2
year from the date of intimation for debarrement besides forfeiture of security deposit
of that product(s).
b) If the supplier supplies more than one item and 50 % of such items are debarred, the
firm is liable to be debarred for a period of 2 years from the date of intimation of
debarment besides forfeiture of security deposit in full.
c) Purchase orders, if any, already issued before taking any blacklisting action or orders
given in past will not be affected in view of action taken as per above guidelines but all
strict quality checks shall be observed for each supply of products.
K. Shelf Life
1. The expiry period of Drugs and other items should not be less than two years unless prescribed
under statutory provisions or schedule "P" in which case it shall not be less than the maximum
prescribed under statutory provisions or Schedule "P" as the case may be.
2. In case where expiry period of drug /item is up to two years, it should not have lapsed the 1/6th
of shelf life at the time of delivery. And in case where expiry period is more than two years it
should not have lapsed 1/4th
of Shelf life at the time of delivery.
3. In case of emergency for products having expiry period 2 years or more Managing Director,
GMSCL, reserves right to accept the goods after getting the written confirmation from RC
holder to take back the unutilized quantity with penalty of 2% of total supply value per month
which have lapsed shelf life mentioned above.
4. In no case stores whose 2/6th
shelf life has lapsed shall be accepted.
5. However the Managing Director GMSCL reserves the right to waive off penalty if the
remaining shelf life of product to be supplied is more than what has been sought in the
tender document.
6. Moreover in case of imported item like vaccine, serum, etc. Managing Director, GMSCL,
reserves right to accept the goods with applicable penalty for packing deviation if any,
after getting the confirmation from the firm to take back unutilized quantity after expiry.
7. In case where product is being supplied does not confirm to the packing standard for e.g.
logo , MRP, Packing size etc.) GMSCL reserves the right to reject the goods.
However if MD GMSCL is satisfied that such packing deviation is non critical in
nature and does not effect the quality of the product, he may with the reason
recorded in writing, accept such goods with the minimum penalty of 3 % for each
such deviation.
8. The stores which have already lapsed shelf life mentioned above will not be accepted.
25 of 51
9. The stores with unpacked or in loose condition will also be not accepted under any
circumstances.
10. Only those bidders shall quote who can manufacture and supply the product with the
required shelf life. The product of labeled shelf life lesser than required shelf life will
not be accepted
11. Quality Assurance: The supplier shall guarantee that the products as packed for shipment (a)
comply with all provisions of specifications and related documents (b) meet the recognized
standards for safety, efficacy and quality; (c) are fit for the purpose made; (d) are free from
defects in workmanship and in materials and (e) the product has been manufactured as per
GMP included in Schedule M of Drugs & Cosmetic Rules.
12. The protocol of the tests should include the requirements given in I.P for tablets and those
required specifically for the product specifications. The Bidder must submit its Test/ Analysis
Report for every batch of drug along with invoice. In case of failure on the part of the
supplier to furnish such report, the batch of drugs will be returned back to the supplier and
he is bound to replenish the same with approved laboratory test report. The supplier shall
provide the validation data of the analytical procedure used for assaying the components and
shall provide the protocols of the tests applied and the placebo material when demanded for the
purpose of testing.
13. The Drugs and medicines supplied by the successful Bidder shall be of the best quality and
shall comply with the specification, stipulations and conditions specified in the Bid documents.
L. PACKING AND LOGOGRAMS
1. The packing, strip and blister of Tab. / Cap. and the labels of all the drugs or other items to be
supplied under the order should be permanently and prominently printed in English & Gujarati
with the words: “FOR THE USE OF GOVT. OF GUJARAT. NOT FOR SALE.” “ U]HZFT
;ZSFZGF p5IMU DF8[ J[RF6 DF8[ GCL” along with logogram. The logogram must be distinct from the
normal trade packing. If the items are packed in packets which are then placed or repacked in a
box / carton / sachet / bottle / foil, these words will be permanently and prominently printed
on both the internal/ external packs and labels along with logogram. The M.R.P. or any other
price must not be printed or not to be shown anywhere either on external pack / box / carton/
foil or on internal packing.( As per Annexure-VI)Logograms /Markings
Logogram means, wherever the context occurs, the design as specified below:-
2. Packing
a) The item shall be supplied in the package schedule given below and the package shall carry the
logogram specified as specified above. The labeling of different packages should be as
specified below. The packing in each carton shall be strictly as per the specification mentioned.
Failure to comply with this shall lead to non-acceptance of the goods besides imposition of
penalties.
b) The pediatric drops should always be supplied with dropper. A measuring cap with suitable
markings must be provided for other paediatric oral liquid preparations.
c) The labels in the case of injectables should clearly indicate whether the preparations are meant
26 of 51
for IV, IM, SC, etc.
d) Injection vials should have flip off seals. The ampules should be provided with ampule foil.
e) Small tablets packed in blisters should be so packed to facilitate removal of tablets without
breaking or crushing.
f) All plastic jars above 450gm/ml should carry an inner plastic lid.
g) The cap of bottles of preparation should not carry the name of the supplier.
h) The medicines stores between 2 to 8 degree (cold and cool storage) Centigrade shall have to
supply in appropriate storage/ transport condition using cold chain supply.
i) All plastic containers should be made of virgin grade plastic.
j) The G e n e r i c name of the drug should be printed in clearly legible bold letters (It is
advisable that the colour of font be different from other printed matter to make the name
highly conspicuous.
k) It should be ensured that only first hand fresh packaging material of uniform size is used for
packing. All packaging must be properly sealed and temper proof.
l) All packing containers should strictly conform to the specifications prescribed in the relevant
pharmacopoeia/Act.
m) Packing should be able to prevent damages or deterioration during transit.
n) In the event of items supplied found to be not as per specifications in respect of their packing,
the stores will not accept the goods.
o) All containers i.e. bottles, tins, cartons, tubes etc. must be secured with pilfer proofs seals to
ensure genuineness of the products packed and the correctness of the contents."A" type plastic
container should conforms to IS:7803 (Part I): 1975 and Polythene plastic bag (Except for
intravenous fluids) should conforms to IS:10141 : 1982.
4. SCHEDULE FOR PACKAGING OF DRUGS AND MEDICINES
GENERAL SPECIFICATIONS
a) No corrugate package should weigh over 15 kgs (i.e. product + inner carton +corrugated
box).
b) All items should be packed only in first hand strong boxes only.
c) Every corrugated box should preferably be of single joint and not more than two joints.
d) Every box should be stitched using pairs of metal pins with an interval of two inches
between each pair.
e) The flaps should uniform meet but should not overlap each other. The flap when turned by 45-
60 should not crack.
f) Every box should be sealed with gum tape running along the top and lower opening.
g) The final packing of cartons of corrugated boxes shall be complying with IS:9313 : 1979 of
November, 1980.
5. CARRY STRAP:
Every box should be strapped with two parallel nylon carry straps (they should intersect.)
6. LABEL:
a) Every corrugated box should carry a large outer label clearly indicating that the product is for
“Govt of Gujarat Supply-Not for Sale” with Logogram of GMSCL.
b) The Product label on the cartoon should be large, atleast 15 cms x 10 cms dimension. It
should carry the correct Generic name, strength or the product, date of manufacturing, date
of expiry quantity packed and net weight of the box. OTHERS:
c) NO box should contain mixed products or mixed batches of the same product.
27 of 51
7. SPECIFICATION FOR CORRUGATED BOXES HOLDING TABLETS/
CAPSULES/ PESSARIES
The total weight of the box should be approx of 7-8 Kgs.
8. SPECIFICATION FOR LARGE VOLUME BOTTLE i.e., ABOVE 100 ml AND
BELOW 1 LIT.
All these bottles should be packed only in single row with partition between each and also
with top and bottom pad of 3 ply.
9. SPECIFICATION FOR IV FLUIDS
Each corrugated box may carry maximum of only 24 bottles of 500 ml in a single row or 50
bottles of 100 ml in 2 rows with individual sealed polythene cover and centre partition pad, top
and bottom pads of 3 ply.
10. SPECIFICATION FOR LIQUID ORALS
a. 100 bottles of 50 ml or 60 ml may be packed in a single corrugated in 2 rows with top, bottom
and centre pad of 3 ply.
b. 50 bottles of 100 ml – 120 ml may be packed in a similar manner in a single corrugated box.
c. If the bottles are not packed in individual carton, 3 ply partition should be provided between
each bottle. The measuring device should be packed individually.
11. SPECIFICATION FOR OINTMENT/ CREAM/GELSPACKED IN TUBES:
a. No corrugated box should weigh more than 7-8 Kg.
b. Every Ointment/Cream/Gel tube should be individually packed in carton and then packed in
20‟s in a grey board box, which may be packed in a corrugated box.
12. SPECIFICATIONS FOR INJECTION (IN VIALS AND AMPOULES)
a. Vials may be packed in corrugated boxes weighing up to 15 Kgs. Ampoules should be
packed in C. B. weighing not more than 8 Kgs.
b. In the case of 10 ml Ampoules or 50 ampoules may be packed in a grey board box. Multiples
of grey board boxes packed in CB. In case of ampoules larger than 10 ml only 25 ampoules
may be packed in a grey board box with partition. If the vial is packed in individual cartoon,
there is no necessity for grey board box packing. The individual cartoon may be packed as
such in the CB with centre pad.
c. In case of ampoules every grey board box should carry 5 amps along with Cutters placed
in a polythene bag.
d. Vials of eye and ear drops should be packed in a individual cartoon with a dispensing device.
If the vial is of FFS/BFS technology, they should be packed in 50‟s in a grey board box.
e. Cutters are not required with ampoules in the case of snap off type ampoules.
13. SPECIFICATION FOR ORS
Primary Packing:- The pouches/sachets of ORS should be three layered with following
composition
Site Material Micron MM g/m
2
Inner Polyethylene 50 0.040-0.050 36.9-46.1
Middle Aluminium 09 0.009-0.015 24.3-40.5
Outside Polyester 12 0.012-0.015 12.9-20.9
28 of 51
Secondary Packages and Tertiary package:- 50 sachets may be packed in grey board boxes and
10 grey board boxes in a Corrugated Box.
M. QUALITY TESTING
1. Sampling of supplies from each batch will be done at the point of supply or distribution/storage
points for testing. (The samples would be sent to different empanelled laboratories for testing
by the ordering authority after coding). The GMSCL will deduct a sum of 1% from the amount
of bill payable to supplier on account of handling and testing charges.
2. The Drugs shall have the active ingredients within the permissible level throughout the
shelf life period of the drug. The samples may also be drawn periodically during the shelf life
period. The supplies will be deemed to be completed only upon receipt of the quality
certificates from the laboratories.
3. Samples which do not meet quality requirements shall render the relevant batches liable to be
rejected. If the sample is declared to be Not of Standard Quality or spurious or adulterated or
misbranded, such batch/batches will be deemed to be rejected goods.
4. The supplier shall furnish to the purchaser, the evidence of bio-availability and bio-equivalence,
polymorph screening report, report of assay and impurities should be submitted for certain
critical drugs when asked for.
5. The products should conform to the standards of IP/BP / USP as the case may be. In case the
product is not included in the said compendium, the supplier, upon award of the contract, must
provide the reference standards and testing protocols for quality control testing. For imported
drugs respective countries pharmacopeia standards shall be acceptable (even if the product is
official in IP).
6. The supply of any item shall be considered complete for the purpose of calculation of
liquidated damages only when reference standards/ standard testing procedure or test
protocol/placebo materials are made available to the corporation along with the supply of
items as per the purchase order. However, these materials and documents shall be made
available by supplier to Quality Cell of GMSCL Headquarter. Such requirement will
communicated by the Headquarter as and when required.
7. In case where the order is placed by Direct Demanding Officer, the sample will be collected by
Drug Inspector of the district or any other officer empowered by him and will be sent for
testing. The decision of the competent drugs control authority will be conclusive and final
and binding to the A.T. / R.C. Holder.
8. If any item is found apparently spoilt / decayed / infected till the expiry date or in case of any
compliant from G.M.S.C.L. / Direct Demanding Officers, the Contractor shall be liable to
replace the unutilized quantity even if the sample is not tested.
9. The samples of stores to be supplied against this rate contract will be drawn by an authorized
person so nominated by the Managing Director, GMSCL, and tested at a laboratory
approved and licensed by the Commissioner, FDCA and nominated by the Managing
Director, GMSCL. The goods will be accepted only if declared to be acceptable as per second
schedule of Drugs & Cosmetics Act, 1940 & respective pharmacopoeia by the said laboratory;
otherwise the supplier will have to take back the goods at his cost. The decision of the
Managing Director will be final and conclusive and no retesting will be allowed. It is further
clarified that such pre-testing will be in addition to the sample testing described in sub-point
(a) of point M(Namely Quality Testing) and will be independent of the replacement /
recovery provisions described in the tender document.
10. It is further clarified that wherever there is a difference in the report of the testing laboratory and
29 of 51
that of the laboratory notified under the Drugs & Cosmetics Act 1940, the latter shall prevail to
the exclusion of the former and no claim whatever based upon the former will be entertained.
11. Further Tenderer should give a written declaration–cum-consent that they shall not supply
rejected drugs to any other Government Organization /Direct Demanding officer. Failing to
which will invite termination of Rate Contract and/or shall be debarred by GMSCL.
12. Replacement Clause:
Note: This clause shall be applicable to sampling & testing under Drugs & Cosmetics
Act, 1940 by notified Drugs Inspector & Govt. Analyst respectively.
If any stores supplied against the A.T./R.C. are found to be of not of standard quality on
inspection and / or analysis by the competent authority, the contractor shall be liable to replace
the entire quantity of the relevant batch within 4 weeks or make full payment of the entire
consignment against the particular invoice, irrespective of the fact that part or full quantity
(batch) of the stores supplied may have been consumed. The decision of the Managing
Director, GMSCL taken on the basis of the report of the competent laboratory regarding
quality will be final and binding. The stock of any item, which has been declared, not of
standard quality shall be withdrawn from all the indenters and will not be returned to the
contractor but will be destroyed by the Organization and the contractor, shall have no claim
over such stores.
Moreover, looking to the time period lapsed in retesting procedure at Central Drugs
Laboratory:-
a) The replacement as aforesaid will not be accepted where retesting is demanded by R.C.
Holder, but only recovery will be done by issue of recovery order so that the questions of
payment of replaced goods does not arise in case the sample is declared standard by Central
Drugs Laboratory. The recovery order as aforesaid is revocable when the batch passes in
retesting.
In case of retesting of substandard drugs, whenever the date of receipt of the test report of
Central Drugs Laboratory, Calcutta declaring the batch as standard quality is close to the
expiry of the batch, Managing Director, G.M.S.C.L., cannot hold the responsibility to use the
unconsumed goods. Under such circumstances the R.C. Holder will have to replace the
unconsumed goods either fully or partially as instructed by Managing Director, G.M.S.C.L.,
and such decision of Managing Director, G.M.S.C.L., based on (a) the duration of reuse and
(b) quantity of unconsumed goods, will be binding on the R.C. Holder.
b) The contractor shall have no claim over unconsumed goods, which shall be destroyed
on the basis of result from Drugs Laboratory, Baroda or shall have no claim over value
thereof.
c) The contractor will not be liable for refund due to unconsumed stock which is very near (3 to
6 months as the case may be depending upon the quantity) to expiry date at the time of receipt
of CDL Report. Refund of only consumed goods will be given in such cases.
Neither, claim for relaxation of replacement period nor for return of goods declared to be not
of standard quality nor any request for acceptance of the replacement goods delayed after the
delivery period (of 4 weeks), due to any reason whatsoever, will be entertained.
N. PAYMENT PROVISION
1. No advance payment towards costs of drugs, medicines etc., will be made to the Bidder.
2. On receipt of the prescribed consolidated invoice duly stamped and signed by authorized
signatory and analytical laboratory report regarding quality, the payment would be made in 30
days.
3. The in charge of district drug warehouse (REGIONAL WARE HOUSE(RWH)) will
acknowledge the drugs received & ensure entry in e- Aushadhi software online.
4. All bills/ Invoices should be raised in duplicate and in the case of excisable Drugs and
30 of 51
Medicines; the bills should be drawn as per Central Excise Rules in the name of the
authority as may be designated. The supplier will deliver following document at the time of
delivery at REGIONAL WARE HOUSE(RWH).
a) In house test report of drug.
b) The challan / invoice copy pertaining to REGIONAL WARE HOUSE (RWH)
5. Payments for supplies will be considered a f t e r receipt of reports of standard quality on
samples having been tested approved laboratories of ordering authority.
6. The bills / invoices are required to be submitted specifying the following details in
appropriate places of the invoices:
a) No. and date of bills or invoice.
b) No. and date of drug license.
c) No. and date of A.T. / R.C.
d) No. and date of order.
e) Name and specification of item.
f) Name of manufacture & Model / Make / Brand.
g) Quantity.
h) Total cost; and
i) Other details like batch , packing unit etc.
j) No. & date of challan (If supply made by challan.
7. The billing shall be in the name of the A.T. / R.C. Holder. The supplies shall be allowed by
authorized dealer as per Rate Contract. Invoice shall be in the name of A.T. / R.C. Holder.
8. The A.T./R.C. Holder shall not charge C.S.T. /VAT, if concerned authority has exempted
them. Further they cannot charge excess amount of Commercial Tax.
9. An amount of Commercial Tax as applicable to be shown separately in the bill/invoice raised.
Further an amount of Commercial Tax so collected should be remitted to the Govt. within
prescribed time limit, otherwise strict action will be taken against defaulters.
10. The payment against supply of stores shall be made within 30 to 45 days from the date of
receipt of the goods in good and acceptable conditions at the destination. However, no
interest will be chargeable by the A.T./R.C. Holder, if the payment is delayed.
11. The payment of the bill shall be made after deducting Government/Corporation dues, if any.
12. The payment of the bills shall be withheld in the following circumstances:
a) The goods are found sub-standard or in non-acceptable conditions.
b) Breach of condition of any contract by the A.T./R.C. Holder.
c) Previous Government dues of A.T./R.C. Holder.
13. Penalty:
a) Unless the penalty is waived by the Managing Director, the A.T./R.C. Holder shall have to
pay the penalty at the rate ½% (half percent) of value of stores per week maximum up to 4
week. On event of failure to supply within delivery period the supplies shall be allowed
with 10 % of penalty for undelivered quantity of stores. in the case the delivery of stores is
not affected within the delivery period.
b) The risk purchase of the items ordered at the cost and risk of the party will be carried out
when the party fails to:
(1) Sign the agreement for entering into contract due to any reason whatsoever in case the offer
is accepted.
(2) Supply the goods / items as per the order placed by either this corporation or by
direct demanding officers in accordance with the main / parallel / substitute rate contracts,
either during the prime / extended validity period or within the delivery period stipulated
above:
31 of 51
(3) The Risk Purchase will be done at any time after the delivery period is over.
(4) The Risk Purchase will be done from Main / Parallel or Substitute R.C. holder
for undelivered quantity of the Stores& the Contractor shall be penalized to the extent of
10% or difference whichever is higher.
(5) GMSCL would also place direct supply order to other organization/ CPSEs as per
government norms in case:-
a. Tenders/ offers are not received or
b. Tenders are not finalized due to any reason or
c. RC holder supplier fails to supply the required / ordered quantity or.
d. In case of emergency / epidemic.
In aforesaid circumstances quotations will be invited from all the CPSEs and placed before
concerned procurement committee for decision. Under such circumstances difference will be
recovered from the concerned RC holder who failed to supply.
c) Any monetary claim arising due to any of the terms and conditions of the tender / supply,
including the difference arising due to risk purchase, will be recovered in the following
manner:-
1) From any pending bills of the party:
2) From any security deposits of the party:
3) If an amount at 1) & 2) is not sufficient to meet an amount of recovery of dues shall be
recovered as arrears of land Revenue Dues under provisions of relevant act.
O. FALL CLAUSE:
1. Attention of the bidders is invited to the higher / lower price certificate and all the bidders /
A.T. / R.C. Holder will have to abide by the terms strictly in accordance with those mentioned
in that certificate. It must be distinctly understood that in case of supply to any institution /
department at price lower than the contracted price within the period specified in the
certificate will immediately invite the reduction in the rates of the contract.
2. Breach of any clause of the certificate will be viewed seriously and action will be taken
against the R.C. / A.T. Holder which may include forfeiture of E.M.D. / S.D., termination of the
contract and disqualification from participating in future business.
P. STANDARD BREACH CLAUSE:
1) The Managing Director of Gujarat Medical Services Corporation Limited, shall in addition to
his powers other clause to terminate this contract have power to terminate his liability there
under of the time by giving one month‟s (or such shorter period as may be mutually agreed):
notice in writing to A.T. / R.C. Holder of his desire to do so and upon expiry of notice the
contract shall be terminated without prejudice to the right accrued to the date of the
termination. However, if the Government decided to put an end to the business relations on
breach of any conditions of the contract, no such notice shall be necessary and on event of
Govt. deciding to terminate the business and the Rate Contract shall stand terminated with
immediate effect.
2) The Rate Contract can also be terminated by the Managing Director in the following
circumstances:
a) If the firm is debarred or disqualified or ceases to exist or convicted of any offence.
b) If the quality of the item to be supplied is found not up to the standard and multiple samples
are found to be not of standard quality.
32 of 51
Q. INSPECTION:
Inspection shall normally be carried out in the premises of the consignee. If goods are offered
for inspection in the factory premises all expenditure shall be borne by the A.T. /R.C. Holder.
The entire store ordered shall have to be offered for inspection in open condition if required and
the same shall be repacked in presence of inspecting team. All packing should be sealed and
signed by inspecting authority and sent to the consignee without any extra cost within three days
from the date of receipt of inspection note. Inspection charges, including the expenses for the
experts, will be payable by the party as per the rates prescribed in the letter of agreement and as
determined by the L.L.C./M.D.L.C./H.L.P.C./B.L.C. from time to time.
R . WARRANTY CLAUSE:
The A.T. / R.C. Holder shall be subjected to the following warranty clause that the
goods/stores/article sold to the buyer under this contract shall be of the best quality to
workmanship and shall be strictly in with the specifications and particulars contained/mentioned
in the acceptance of tender and the contract/seller would continue to confirm to the
description and quality of for period of the shelf life for the product and notwithstanding the
fact that the purchaser (inspector) may have inspected and / or approved the said goods / stores /
articles be discovered of the purchaser in that behalf will be final and conclusive the
deteriorated and the decision of the purchaser will be entitled to reject the said goods / stores /
articles or such portion rejections the goods /stores / articles will be at the sellers risk and all
the provisions here in contained relating rejection of goods etc. shall apply. The contractor /
seller shall if, so called upon to do replace within a period of month of such further period as
may be extended from time to time by the purchaser in its discretion on an application made
thereof by the contractor / seller the goods / stores / articles or such portion thereof is its rejected
in by the purchaser and in such on even above mentioned warranty period shall be pay to
purchaser such damages as may arise by reasons for the breach of the conditions herein
contained. Nothing herein contained shall prejudice any other right of the purchaser in that behalf
under this contract or otherwise.
S. JURISDICTION:
The jurisdiction of any dispute will be Gandhinagar or Ahmedabad.
33 of 51
ANNEXURE - I
Verification, Undertaking, Checklist & Documents
(ON STAMP PAPER OF Rs.20.00 & TO BE NOTARIZED)
From: M/s. No.
To: The Managing Director,
Gujarat Medical Services Corporation Limited,
Regd. Office: Block No.14, Dr.Jivraj Mehta Bhavan
Sector-10, Gandhinagar-382 010.
Sub: Supply of Drugs / Medicine / Surgical goods etc.
Ref: Tender Enquiry #
Sir,
I/We enclose the priced tender form duly signed & Stamped. Necessary documents are
enclosed herewith (in order in which are mentioned). The rates quoted against each item are
inclusive of excise duties and other charges. I/We shall abide by all these conditions. I/We hereby
undertake to supply the goods to the consignees as per the terms of the A.T./R.C.
I/We verify that the copies of the certificates / documents attached herewith are authentic
true copies of the original certificates / documents and I/We undertake to produce the original
certificates / documents for verification on demand. I/We undertake to supply the attested copies of
certificate / documents required at the time of signing the letter of agreement if my/our offer is
accepted.
I/We verify that I/We are in possession of the requisite licenses / permits required for the
manufacturer / supply / sale /distribution of the items and further verify that the said licenses /
permits have not been revoked /cancelled by the issuing authorities and are valid as on date. I/We
also verify that I/We have not been blacklisted / debarred / stopped from supply of the items quoted
in the Tender Enquiry by any Government Department / Organization / undertaking in India.
I/We also take cognizance of the fact that providing misleading or questionable information
or failure to furnish correct or true information to you or any other Direct Demanding Officer or
failure to comply with any contractual requirement laid down by you / them will be considered as a
serious breach of the terms and conditions of the tender and will invite disqualification and other
penal action as deemed fit by the Government / Purchase Committee, G.M.S.C.L.
Thanking you,
Date:
Yours faithfully,
34 of 51
ANNEXURE-II (REF.
CLAUSE NO.12)
(FORMAT OF AFFIDAVIT OF PROOF OF MANUFACTURING EXPERIENCE
MARKETING DATA)
(ON STAMP PAPER OF Rs.20.00 & TO BE NOTARIZED)
I .age . residing at
. in capacity of M/s.
.hereby solemnly affirm that…..
1. M/s. . have manufactured / imported sold &
paid Commercial Tax on the said sales of their products as detailed below:
Sr.
No.
Name of Item Very first batch
of product
manufactured /
imported for
marketing
Year wise
period
Continuance of production &
marketing of year wise
Date Qty. Mfg/
Importe
d
quantity
Total
Nos of
commer
tial
Batches
Sold
Qty
.
Sale
Value
{Rs.
Lakhs}
2015-2016
2016-2017
2017-2018
2. That on the basis of the above facts & figures M/s. has
manufactured / marketed their above products the period at least year{s} prior to the due date of
Tender Enquiry No. as per the specifications mentioned in the tender.
Whatever stated above is true & correct to the best of my knowledge & belief.
Date: {SIGNATURE & STAMP OF THE AUTHORISED SIGNATORY}
35 of 51
ANNEXURE – III
HIGHER PRICE / LOWER PRICE CERTIFICATE
1. I/We . hereby certify
that the prices quoted by us in Tender Enquiry # . are not higher than the prices:
{a} charged by us to wholesalers or for institutional supplies;
{b} allowed under D.P.C.O. for wholesale / institutional supplies {where
applicable}.
2. I/We further certify that I/We have not supplied or quoted for any item in Tender Enquiry #
. at prices lower than those quoted for the relevant items to any Government
/Semi Government / Public / Charitable Trust Organization / Institution within the period of
180 days preceding the last date of submission of the tender.
3. I/We hereby undertake that I/We will not supply or quote for any item in Tender Enquiry #
. at prices lower than those quoted for the relevant items to any Government /
Semi Government / Public / Charitable Trust Organization / Institution within the period of
validity of the offer / rate contract.
4. I/We also undertake to bring to the attention of the Managing Directorany incidence of
breach of any of the above paras within 30 days from the occurrence of the breach and
further undertake to refund / reimburse the difference which may arise due to breach of any
of the above paras and I/We also understand that the decision of Managing Directorregards
to the determination of quantum payable shall be final.
Date: {SIGNATURE &STAMP OF THE AUTHORISED SIGNATORY}
Gujarat Medical Services Corporation Limited (A Government of Gujarat Undertaking)
Gandhinagar.
ANNEXURE-IV
Affidavit
(TO BE SUBMITTED PHYSICALLY)
(To be submitted IN ORIGINAL on Non-Judicial Stamp Paper of Rs.100/- duly attested by
First Class Magistrate / Notary Public)
I/We ___________________________________ Age_________ years residing at
_________________________________ in capacity of _____________________________________ M/s.
__________________________________________ hereby solemnly affirm that
1 All General Instructions, General Terms and Conditions, as well as Special Terms & Conditions
laid down on all the pages of the Tender Form, have been read carefully and understood properly
by me which are completely acceptable to be and I agree to abide by the same.
2 I / We have submitted following Certificates / Documents for T.E. as required as per General
Terms & Conditions as well as Special Terms & Conditions of the tender.
Sr. No. Name of the Document
1
2
Onwards
3 All the Certificates / Permissions / Documents / Permits / Affidavits are valid and current as on
date and have not been withdrawn / cancelled by the issuing authority.
4 It is clearly and distinctly understood by me that the tender is liable to be rejected if on scrutiny
at any time, any of the required Certificates / Permissions / Documents / Permits / Affidavits is /
are found to be invalid / wrong / incorrect / misleading / fabricated / expired or having any
defect.
5 I / We further undertake to produce on demand the original Certificate / Permission / Documents
/ Permits for verification at any stage during the processing of the tender as well as at any time
asked to produce.
6 I / We also understand that failure to produce the documents in "Prescribed Proforma"
(wherever applicable) as well as failure to give requisite information in the prescribed Proforma
may result in to rejection of the tender.
7 My / Our firm has not been banned / debarred / black listed at least for three years (excluding
the current financial year) by any Government Department / State Government / Government of
India / Board / Corporation / Government Financial Institution in context to purchase procedure
through tender.
8 I / We confirm that I / We have meticulously filled in, checked and verified the enclosed
documents / certificates / permissions / permits / affidavits / information etc. from every aspect
and the same are enclosed in order (i.e. in chronology) in which they are supposed to be
enclosed. Page numbers are given on each submitted document. Important information in each
document is "highlighted" with the help of "marker pen" as required.
9 The above certificates / documents are enclosed separately and not on the Proforma printed from
tender document.
36 of 51
Gujarat Medical Services Corporation Limited (A Government of Gujarat Undertaking)
Gandhinagar.
10 I / We say and submit that the Permanent Account Number (PAN) given by the Income Tax
Department is _________________________________ which is issued on the name of
______________________________________________ [kindly mention here either name of the Proprietor (in
case of Proprietor Firm) or name of the tendering firm, whichever is applicable].
11 I / We understand that giving wrong information on oath amounts to forgery and perjury, and
I/We am/are aware of the consequence thereof, in case any information provided by us are
found to be false or incorrect, you have right to reject our bid at any stage including forfeiture of our EMD/PBG/cancel the award of contract, in this event. This office reserves the right to take
legal action on me/us.
12 I / We have physically signed & stamped all the above documents along with copy of tender
documents (page no _________ to __________
13 I / We hereby confirm that all our quoted items meet or exceed the requirement and are
absolutely compliment with specification mentioned in the bid document.
14 My / Our company has not filed any Writ Petition, Court matter and there is no court matter filed
by State Government and its Board Corporation, is pending against our company.
15 I / We hereby commit that we have paid all outstanding amount of dues / taxes / cess / charges /
fees with interest and penalty.
16 In case of breach of any tender terms and conditions or deviation from bid specification other
than already specified as mentioned above, the decision of Tender Committee for disqualification
will be accepted by us.
17 Whatever stated above is true and correct to the best of my knowledge and belief.
Date: Stamp & Sign of the Tenderer
Place: (Signature and seal of the Notary)
37 of 51
Gujarat Medical Services Corporation Limited (A Government of Gujarat Undertaking)
Gandhinagar.
ANNEXURE-V
Gujarat Medical Services Corporation Limited,
Gandhinagar.
1. All Glass bottles should be new neutral Glass.
2. Small Tablets Packed in blisters should be so packed to facilitate
removal of the tablet without breaking/crushing.
3. All plastic containers should be made of virgin grade plastics.
4. All plastics jars above 450 gm./ml. should carry an inner plastic lid.
5. Packing should be able to prevent damage or deterioration during transit.
6. The medicines stored between 2o
C to 8o
C shall have to supply in
thermocol box with Ice pack.
7. The Cap of bottles of preparation should not carry the name of the
supplier.
8. The labels in the case of injectables should clearly indicate
whether the preparations are meant for IV, IM, SC etc.
9. Only first use packing material of uniform size including bottle and vial
is used for making supplies.
10. The tenderer must submit a test analysis report from a NABL
laboratory/Government Approved (FDCA Approved)Public Testing
laboratory for every batch of drugs along with consignment.
11. All primary packing, containers should be strictly conforming to the
specifications, included in the relevant Pharmacopoea.
12. In case a box of 100 Strips, 10 Strips should be packed with paper
Strip / Cellopham / Rubber band.
13. For Oral dosage liquid preparation, a measuring cap must be
provided with suitable markings.
38 of 51
Gujarat Medical Services Corporation Limited (A Government of Gujarat Undertaking)
Gandhinagar.
ANNEXURE-VI
SPECIMEN LABEL
FOR
OUTER CARTON
GUJARAT GOVT.
SUPPLY NOT
FOR SALE
U]]H]]HZFT ;ZSFZGF p5IMU DF8[[[[ v J[[R[[RF6 DF8[[[[ GCL\\\\
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ DELTAMETHRIN 2.5%
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
EXP. DATE : June- 2019
Batch No: Quantity Packed:
Mfg. Date: _ Net Weight: _
Manufactured by: _
39 of 51
Gujarat Medical Services Corporation Limited (A Government of Gujarat Undertaking)
Gandhinagar.
ANNEXURE-VII
STATEMENT OF CAPACITY OF PRODUCTION
01. Name of firm :
Address :
Telephone /Fax /Mobile No. :
E-mail Address :
Name of responsible person to be contacted
02. The installed capacity of this firm is as follows:
Dry Tablets Vials
Capsules Bottles
Wet Internal
(liquids and colloids)
Syrups Ampoules
External
Liquids
Creams Drops/Ointments
Ointments
Signature of the bidder:
Full Name (IN BLOCK LETTERS)
Note:Details are to be provided for one month's production capacity.
Sr.
No.
Name of Certificate Particulars Validity
1. Gujarat Commercial Tax No.
2. Central Sales Tax No.
3. Drug Manufacturing License No.
4. Whole sale Drug License No.
5. WHO GMP No.
6. CSPO Reg. No.
7. Micro/small enterprise Reg. No. (As per old or new acknowledgement)
40 of 51
Gujarat Medical Services Corporation Limited (A Government of Gujarat Undertaking)
Gandhinagar.
ANNEXURE-VIII
(FORMAT OF AUTHORIZATION LETTER FOR AUTHORIZED DISTRIBUTOR)
{IN ORIGINAL}
(IN CASE OF IMPORTED ITEMS)
I / We hereby declare that....
1. M/s. is our
authorized distributor for our products in India from date and they are authorized to quote
and follow up on our behalf and the said agreement is valid in force as on date;
2. I/We undertake to supply the drugs / items for which the quotations of following items are submitted
by M/s. on our behalf in
respect of Tender Enquiry # :
Sr.No. Item No. Name of Item
(1)
(2)
3. I / We have read all the terms and conditions of the tender enquiry and the same are irrevocably
binding upon us till the expiry of the contract signed & executed on our behalf;
4. I/We shall notify the Managing Director,G.M.S.C.L. immediately if there is any change in the
agreement between M/s. and me/us regarding
authorized distributorship of our products and further undertake to supply the items quoted by the
distributor on my / our behalf at the quoted in the tender enquiry in case of such a change of
agreement.
5. This authority is applicable only for Tender Enquiry # .
Date:- Signature of Authorized Signatory
41 of 51
Gujarat Medical Services Corporation Limited
(A Government of Gujarat Undertaking) Gandhinagar.
ANNEXURE-IX
(REF.CLAUSE NO 24 )
{ FORMAT OF AFFIDAVIT OF DECLARATION ABOUT
DEBARMENT OF MANUFACTURER FOR THE ITEMS QUOTED}
{ON STAMP PAPER OF RS. 20.00 & TO BE NOTARIZED}
I age residing at
in capacity of M/s. hereby solemnly
affirm that………..
1. M/s. is not debarred or blacklisted by Gujarat Medical
Services Corporation Limited (GMSCL) or for Failure in supply of Quality drugs by any State/
Central Government / Undertaking / Organization for the items quoted at present to the due date of
Tender Enquiry #
2. I / We undertake responsibility to bring attention of The Managing Director, Gujarat Medical
Services Corporation Limited (GMSCL), Gujarat State Gandhinagar, if tenderer will be debarred /
blacklisted by Gujarat Medical Services Corporation Limited (GMSCL) or for Failure in supply of
Quality drugs in future by any State/ Central Government / Undertaking / Organization..
3. I / We state that I / We am/are observing all the conditions of the drug licenses and provision of the
drug & cosmetics ACT-1940 and rules there under meticulously. Further I / We undertake that I /
We shall remain scrupulous in observing the various provisions of the drug & cosmetics ACT- 1940,
Amendment there in and rules there under throughout the contract period.
DATE: {SIGNATURE & STAMP OF THE AUTHORIZED SIGNATORY}
{SIGNATURE & STAMP OF THE NOTARY}
42 of 51
ANNEXURE-X
CHECKLIST FOR TENER SUPPORTING DOCUMENTS
Sr. No Particulars GR
OUP
Date of
Issue Encircle
Yes/ No Remark
s 1 Copy of valid Drug Licence
& renewal of Drug Licence
(Manufacturing).
A
Yes/ No
2 Product permission A
Yes/ No
3 Import License (if applicable) A
Yes/ No
4 Affidavit of marketing Data
(As per format Annexure-II) B
Yes/ No
5 C.A. Certificate for Annual turnover of
firm A
Yes/ No
6 C.A. Certificate for showing year wise
Production & Turnover of quoted item . A
Yes/ No
7 WHOGMP Certificate A Yes/NA
8 Higher-Lower price certificate
(As per format Annexure-III) A
Yes/ No
9 PAN Card copy A Yes/ No
10 Non-conviction certificatefrom
F.D.C.A.(As per format Annexure-XII) A
Yes/ No
11 Performancecertificatefrom
F.D.C.A.(As per format nnexure-XI) A
Yes/ No
12 VAT Clearance Certificate (Last Financial Year) / Certified copy of VAT Return Mentioning Zero Outstanding (Last Financial Year).
A
Yes/ No
13 ISI Certificate A Yes
14 ISO Certificate A Yes/ No/NA
15 Micro/small enterprise Registration
certificat e in new acknowledgement. (As
per the Gazette of India Act-2006).
A
Yes/ No
16 CSPO / NSIC / DGS& D/ KVIC
registration certificate. A
Yes/ No
17 Affidavit of format of Certificates
(As per format Annexure-IV) B
Yes/ No
18 Authorization letter to a Senior
responsible Officer of the firm A
Yes/ No
19 Constitution of the firm (memorandum,
articles of association, partnership deed
etc.)
B
Yes/ No
20 Authorizationletterfor authorized
distributor.(In case of Imported Items)
(As per format Annexure-VIII)
Authorizationletterfor authorized
distributor.(In case of Imported Items)
(As per format Annexure-VIII)
A
Yes/ No
21 Undertaking&Verification of
Documents (As per format Annexure I)
(ON STAMP PAPER OF Rs.20.00 &
TO BE NOTARIZED)
B
Yes/ No
22 Statement of Capacity of
Production
(As per format Annexure VII)
A
Yes/ No
23 Undertaking from where the supplies is
made. (For Out statetenderer whose
supplies made from Gujarat Depot.)
A
Yes/ No
24 Valid wholesale Drug License. (For Out
statetenderer whose supplies made from
Gujarat Depot.)
A
Yes/ No
25 Goods and Service Tax (GST) or Gujarat
sales Tax (VAT) registration certificate
&clearance certificate. (For Out state
tenderer whoses supplies made from
Gujarat depot.)
A
Yes/ No
26 Affidavit of Declaration about debarment
of manufacturerfor the items quoted
(As per format Annexure-IX)
B
Yes/ No
27 Self Certified / notarized copy of latest
audited annual balance sheet and
information providing their Investment in
plant and machinery to prove their present
status as an SSI Unit of Gujarat State.
B
Yes/ No
28 FFS certificate from FDCA. A Yes/ No/NA
29. Self-attested copy of Certificate from
Practicing Chartered Accountant or
Practicing company Secretary that the
unit / bidder still continues to be Small
Scale, Tiny/ Cottage Industry
A
Yes/ No
30 E.M.D. B Yes/ No/NA
31 TENDER FEE B Yes/ No/NA
32 Sales Tax (VAT) / CST / Goods and
Service Tax (GST)registration copy
A Yes/ No
It is verified that all the certificates / permissions / documents are valid and current as on
date and have not been withdrawn / cancelled by the issuing authority. It is further verified that
the certificates are as per the format given by GMSCL/Concerned authority and it is clearly
and distinctly understood by me / us that the tender is liable to be rejected if on scrutiny of
these certificates it is found to be not as per the prescribed format of GMSCL
I/We further undertake to produce on demand the original certificate / permission /
document for verification at any stage during the processing of the tender.
{SIGNATURE & STAMP OF THE TENDERER)
Note: The documents are differentiated in 2 parts Group-A & Group-B. Documents
classified in Group-A should be submitted online only and Group-B should be submitted
physical only, otherwise tender will be rejected. All required documents not mentioned
above must be submitted physically only. Price Tender Form (General Terms & Conditions
copy) is not required to be submitted.
Date:
Place :
45 of 51
Gujarat Medical Services Corporation Limited
(A Government of Gujarat Undertaking) Gandhinagar.
ANNEXURE-XI
(FORMAT OF PERFORMANCE CERTIFICATES)
Name and Address of concern FDCA
PERFORMANCE CERTIFICATE
On the basis of record / Information available in this office, this is to certify that up to time
of writing of this certificate, the performance of M/s
holding drug manufacturing licenses No.
is satisfactory.
It is further certified that the conditions of the drug licenses and all the provisions of the
drug and cosmetics Act 1940 and rules there under being observed by M/s.
Meticulously.
Date: SIGNATURE & STAMP OF THE AUTHORISED SIGNATORY
(CONCERNED FDCA)
46 of 51
ANNEXURE-XII
(FORMAT OF NON-CONVICTION CERTIFICATES)
Name and Address of concern FDCA
NON-CONVICTION CERTIFICATE
On the basis of the record / Information available in this office, this is to certify that M/s
have been granted drug
manufacturing licenses in Form No. 25 bearing No. & Form No. 28 bearing
No. under the provision of drugs & Cosmetics Act-1940 and rules there
under and that the said manufacturer has not been convicted for violation of provision of drugs &
Cosmetics Act-1940 & Rules there under during the preceding years.
It is further certified that the conditions of the drug licenses and all the provisions of the
drug and cosmetics Act 1940 and rules there under being observed by M/s.
Meticulously.
Date: SIGNATURE & STAMP OF THE AUTHORISED SIGNATORY
(CONCERNED FDCA)
47 of 51
ANNEXURE-XIII
List of Miscellaneous items for SSI units for Turnover condition No-12Vii(B)
Sr No Item code Name of Item
1 3016 Black Disinfectant Fluid Grade III Liq 5 litre jar
2 3017 Bleaching Powder Grade II I.S.I.Mark 5kg Bag
3 3018 Bleaching Powder Grade II I.S.I.Mark 25kg Bag
4 3023
Chlorhexidine Gluconate Soln 4% w/v
5 3031 Lysol (Cresol with Soap Solution)
(Cresol 50% + Soap 50%)
6 3057 Gamma Benzene Hexachloride Lotion 1%
7 3060 Gention Violet Topical Soln.
8 3061 Glutaraldehyde Soln 2% w/v
9 3078 Liquid Antiseptic (1 Litre)
10 3099 Povidone Iodine Solution 7.5% 1 Litre Bottle
11 3100 Povidone Iodine Solution 5% 1 Litre Jar
12 3109 Sodium Hypochlorite Solution 5 Liter Jar
13 3173 Liniment of Turpentine (30ml bottle)
14 3175
Compound Benzoin Tincture 500 ml Bottle
15 4022 Plaster Of Paris Bandage (10cm x 2.7mtr)
16 4023 Plaster Of Paris Bandage (15cm x 2.7mtr)
48 of 51
Tender Enquiry No. GMSCL/D-629/RC/2018-2019
SCHEDULE TO STANDARD, COMPOSITION, PACKING, EMD, MINIMUM BATCH SIZE,
WHOGMP, PACKING PER CARTON, APPROX. TWO YEARS REQUIREMENT ETC.
Attached excel file named TEEXCEL629.pdf
49 of 51
BIDDING SCHEDULES
Document Fee
Furnish the Payment Details of Tender Document
Sr. No Description Supplier Response
1. Amount (Rs.)
2. Bank Name
3. DD No.
4. Branch Name
Payment made toward document fee will not be refunded
Non payment of the document fee will be make the supplier liable for disqualifications
Wrong/ Fraudulent data submission may lead to disqualification, please ensure that you
furnish correct data
EMD
Furnish the Payment Details of EMD
Sr. No Description SupplierResponse
1. Amount in Rs.
2. Bank Name
3. Branch Name
4. DD / Bank
GuaranteeNo.
5. Date of DD / BG
Payment should be made by DD / BG, DD should be payable at Gandhinagar at any schedule
bank
Payment should be made in favor of "Gujarat Medical Services Corporation" Gandhinagar,
Gujarat, India
Payment made towards EMD will not be refunded unless bid is accepted
Nonpayment of the EMD or in sufficient amount of EMD will be make the supplier liable for
disqualifications
Wrong/ Fraudulent data submission may lead to disqualification, please ensure that you
furnish correct data.
50 of 51
Technical Item
No.
Name of
Item
Specification Packing Mfg by / at Offer Brand Specify
Packing Remarks
Commercial
Item
No.
Name
of
Item
Specification Packing Rates without
applicable
GST
per Liter
GST if
applicable
(In %)
Total Rate with
applicable GST
(%)
Total
Rates
(inwo
rds)
Rema
rks
SGST CGST IGST Total
GST
Note:
(1) Rate should be quoted very carefully as per packing unit.
a) The above quoted rates are inclusive of GST, Packing, Forwarding and Insurance charges F.O.R.
Destination anywhere in Gujarat.
b) I/We hereby confirm that the items quoted above conform to the standards, composition and packing as
shown in the schedule.
c) If GST is not applicable or exempted then enter “0” and specify in remarks column “No Tax (for GST)”
or “Exempted (for GST)”.
51 of 51
1
ANNEXURE TO SCHEDULE
Specification
ITEM CODE: 3013 NAME OF ITEM: HbSAg – Rapid TestKitfordetection of Hepatitis B surface Antigen (HbSAg) in Plasma / Serum.
(i) Non “ELISA reader”based test, immune chromatographic method
(ii) Kit must bebased on detection of Hepatitis B surface antigen (HBsAg) in plasma&
serum.
(iii) Suitableforprocessing of even single sample.
(iv) Sensitivity and specificity should beasperWHO standards.
(v) Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.
(vi) Kit should be stored & transported at 2* to 8* C temperature.
(vii) Controls must be provided with test kit.
(viii) The kit should be supplied complete with necessary accessoriesrequiredfor the test.
(ix) Kit should be FDA / CE approved.
(x) Detailed literature regarding kit should be provided along with tender
2
ANNEXURE TO SCHEDULE
Specification
ITEM CODE: 3138
NAME OF ITEM: HCV Elisa TestKit Hepatitis C virusantibody detection3rd Generation test
(ELISA)
1. Should detect antibodies against HCV in human serum orplasma by ELISA test method.
2. Kit should be “ELISA reader” based test.
3. Specificity &SensitivityasperWHO standards
4. Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.
5. Kit should be stored & transported at 2* to 8* C temperature
6. The kit should be supplied complete with necessary accessoriesrequiredfor the test.
7. Controls must be provided with test kit.
8. Kit should be FDA / CE approved
9. Detailed literature regarding kit should be provided along with tender
3
ANNEXURE TO SCHEDULE
Specification
ITEM CODE: 3139 NAME OF ITEM: HCV Rapid TestKit Hepatitis C Virus 3rd Generation Test (Rapid)
(i) Should detect anti bodies against HCV in human serum or plasma.
(ii) Testkit should benon “ELISA reader”base/ immunochromatographic test.
(iii) Specificity &SensitivityasperWHO standards
(iv) Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.
(v) Kit should be stored & transported at 2* to 8* C temperature
(vi) The kit should be supplied complete with necessary accessoriesrequiredfor the
test.
(vii) Controls must be provided with test kit.
(viii) Kit should be FDA / CE approved
(ix) Detailed literature regarding kit should be provided along with tender
4
ANNEXURE TO SCHEDULE
Specification
ITEM CODE: 3143
NAME OF ITEM: PregnancyTestKit forHCG detection
1. A rapid immunochromatographicimmunoassay forqualitativedetection of human Chronic
Gonadotropin (HCG) in urine.
2. Should be able todetect presence of HCG in urine at sensitivity of 20 to 30 MIU/ml
3. Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.
4. Kit should be stored & transported at 2* to 8* C temperature
5. The kit should be supplied complete with necessary accessoriesrequiredfor the test.
6. Controls must be provided with test kit.
7. Kit should beISO approved
8. Detailed literature regarding kit should be provided along with tender
.
5
ANNEXURE TO SCHEDULE
Specification
ITEM CODE: 3157
NAME OF ITEM: Serum RPRTestKit (RPR test)
1. Kit should becardiolipin antigen based RPRtest kit. Antigen should be carbon particle
coated with cardiolipin antigen.
2. Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.
3. Kit should be stored & transported at 2*C to 8* C temperature
4. Sensitivityshould beasperWHOstandards
5. The kit should be supplied complete with necessary accessoriesrequiredfor the test.
6. Controls must be provided with test kit.
7. Kit should be FDA / CE / ISO approved
8. Detailed literature regarding Kit should be provided along with tender.
6
ANNEXURETO SCHEDULE
Specification
ITEM CODE: 3158 NAME OF ITEM: Serum WidalTestKit (Rapid Slide Test)
1. Kit should have Stained salmonella antigens for "O", “H," Para-A, Para-B,
2. Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.
3. Kit should be stored & transported at 2*C to 8*C temperature
4. The kit should be supplied complete with necessary accessoriesrequiredfor the test.
5. Controls must be provided with test kit.
6. Kit should beISO approved
7. Detailed literature regarding Kit should be provided along with tender.
7
J
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
1 1001Acetazolamide
Tablets 250mgIP
Each Tablet contains:
Acetazolamide IP 250mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes
100
Box1153000 Tablet 28700
2 1005Acyclovir
Tablets 200mgIP
Each Tablet contains:
Aciclovir IP 200mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes
100
Box3907000 Tablet 84400
3 1006Albendazole
Tablets 400mg IP
Each Chewable Tablet contains:
Albendazole IP 400mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes
20
Box114382000 Tablet 785700
4 1012Amitriptyline HCL
Tablets 25mgIP
Each Coated Tablet contains:
Amitryptiline Hydrochloride IP
25mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes
200
Box10012000 Tablet 50300
5 1013Amlodipine
Tablets 5mgIP
Each Tablet contains:
Amlodipine Besylate IP eq.to
Amlodipine 5mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes
50
Box67451000 Tablet 121400
6 1016Amoxycillin
Capsules 500mgIP
Each Capsule contains:
Amoxycillin Trihydrate IP eq.to
Amoxycillin 500mg
Box of 10x10 Cap. In
Alu.Foil Strip/Blister with
Alu.back ($)
2 Years 100000 Yes100
Box 132661000 Capsule 5153900
7 1017Amoxycillin
Capsules 250mgIP
Each Capsule contains:
Amoxycillin Trihydrate IP eq.to
Amoxycillin 250mg
Box of 10x10 Cap. In
Alu.Foil Strip/Blister with
Alu.back ($)
2 Years 400000 Yes100
Box92290000 Capsule 1911800
8 1018
Amoxycillin
Dispersible
Kid Tablets 125mg
IP
Each Dispersible Tablet contains:
Amoxycillin Trihydrate IP eq.to
125mg of Amoxycillin in
suitable dispersible base
Box of 100x10 Tab. In
Alu.Foil Strip/Blister with
Alu.back
2 Years 400000 Yes30
Box64842000 Tablet 756000
9 1021
Ascorbic Acid
Tablets 500mg
Chewable
---
Each Uncoated Tablet contains:
Ascorbic Acid IP 100mg,
Sodium Ascorbate IP 450mg
(eq. to 400mg of Ascorbic acid)
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes
20
Box64418000 Tablet 910800
10 1023Atenolol Tablets
50mgIP
Each Tablet contains:
Atenolol IP 50mg
Box of 100x14 Tab. In
Blister with Alu.back 2 Years 400000 Yes 20 Box 131763000 Tablet 417900
Schedule to STANDARD, COMPOSITION, PACKING UNIT, EMD, MINIMUM BATCH SIZE, WHOGMP, PACKING PER CARTON, APPROX. REQUIREMENT
T.E.No.GMSCL/D-629/RC/2018-2019
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
11 1025
Benzhexol Tablets
(Trihexyphenidyl)
2mg
IPEach Tablet contains:
Benzhexol Hydrochloride IP 2mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 9294000 Tablet 20000
12 1026Bisacodyl Tablets
5mgIP
Each Enteric Coated Tablet contains:
Bisacodyl IP 5mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 200000 Yes 30 Box 20069000 Tablet 98100
13 1031Carbamazepine
Tablets 200mg IP
Each Tablet contains:
Carbamazepine IP 200mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 200000 Yes 30 Box 13262000 Tablet 288000
14 1034Cefadroxil Kid
Tablets 125mg---
Each Dispersible Tablet contains:
Cefadroxil IP eq.to Anhydrous
Cefadroxil 125mg
Box of 100x10 Tab. In
Alu.Foil Strip/ Blister
with Alu.back
2 Years 400000 Yes 30 Box 35818000 Tablet 639400
15 1039Chloroquine Tablets
250mgIP
Each Coated Tablet contains:
Chloroquine Phosphate IP 250mg
Box of 100x10 Tab. In
Blister Strip packing with
transparent top
2 Years 400000 Yes 20 Box 121488000 Tablet 646100
16 1040Chloroquine Tablets
500mgIP
Each Coated Tablet contains:
Chloroquine Phosphate IP 500mg
Box of 10x10 Tab. In
Blister Strip packing with
transparent top ($)
2 Years100000
Yes 20 Box 760000 Tablet 20300
17 1041Chlorpheniramine
Maleate Tablets 4mg IP
Each Tablet contains:
Chlorpheniramine Maleate IP 4mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 800000 Yes 50 Box 553014000 Tablet 615500
18 1051Clotrimazole Vaginal
Tablets 100mg IP
Each Vaginal Tablet contains:
Clotrimazole IP 100mg
Box of 25x6 Tab. In
Alu. Foil strip ($)2 Years 100000 Yes 50 Box 7073000 Tablet 151800
19 1059Dexamethasone
Tablets 0.5mgIP
Each Tablet contains:
Dexamethasone IP 0.5mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 66053000 Tablet 193000
20 1060Diazepam
Tablets 5mgIP
Each Tablet contains:
Diazepam IP 5 mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 11317000 Tablet 32600
21 1061Diclofenac Sodium
Tablets 50mg IP
Each Enteric coated Tablet contains:
Diclofenac Sodium IP 50 mg.
Box of 100x10 Tab. In
Blister with Alu.back2 Years 800000 Yes 50 Box 489067000 Tablet 1427600
22 1062Dicyclomine
Tablets 20mgIP
Each Tablet contains:
Dicyclomine Hydrochloride IP 20mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 114182000 Tablet 209000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
23 1063Diethylcarbamazine
Citrate Tablets 100mgIP
Each Tablet contains:
Diethylcarbamazine Citrate IP
100mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes 200 Box 1672000 Tablet 7500
24 1064Digoxin Tablets
0.25mg IP
Each Tablet contains:
Digoxin IP 0.25mg
Box of 10x10 Tab. In
Aluminium Foil Strip ($)2 Years 200000 Yes 200 Box 2165000 Tablet 23300
25 1065Diloxanide Furoate
Tablets 500mgIP
Each Tablet contains:
Diloxanide Furoate IP 500mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 200000 Yes 100 Box 839000 Tablet 25000
26 1068Domperidone
Tablets 10mgIP
Each Tablet contains:
Domperidone Maleate IP
eq.to Domperidone 10mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 88724000 Tablet 231900
27 1071Doxycycline
Capsules 100mg IP
Each Capsule contains:
Doxycycline Hydrochloride IP
eq.to Doxycycline 100mg
Box of 10x10 Cap. In
Blister with Alu.back ($)2 Years 400000 Yes 100 Box 156791000 Capsule 851300
28 1072 Enalapril Tablets 5mg IPEach Tablet contains:
Enalapril Maleate IP 5 mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 80623000 Tablet 267700
29 1075Eteophylline &
Theophylline Tablets---
Each Tablet contains:
(1) Eteophylline IP/BP 77mg
(2) Theophyline IP 23mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 30 Box 102632000 Tablet 444300
30 1081Ferrous Sulphate
Tablets 200mgIP
Each Sugar coated Tablet contains:
Dried Ferrous Sulphate IP 200mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 30 Box 68346000Tablet 154300
31 1083Fluoxetine
Capsules 20mg IP
Each Capsule contains:
Fluoxetine Hydrochloride IP
eq.to Fluoxetine 20 mg
Box of 10x10 Cap. In
Alu. Foil Strip ($)2 Years 200000 Yes 100 Box 7993000 Capsule 73100
32 1084
Folic Acid & Ferrous
Sulphate Tablets
(Small) IP
Each Enteric coated Tablet
contains:Exsiccated
Ferrous Sulphate IP 67mg eq.to
20mg of elimental Iron;
Folic Acid IP 0.1mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 800000 Yes 30 Box 486968000 Tablet 154000
33 1086Folic Acid
Tablets 5mg IP
Each Tablet contains:
Folic Acid IP 5mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 800000 Yes 50 Box 180992000 Tablet 462000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
34 1087Frusemide
Tablets 40mgIP
Each Tablet contains:
Frusemide IP 40 mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 24833000 Tablet 111400
35 1093Haloperidol
Tablets 5mgIP
Each Tablet contains:
Haloperidol IP 5mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 200000 Yes 200 Box 1735000 Tablet 5000
36 1096Ibuprofen
Tablets 400mgIP
Each Coated Tablet contains:
Ibuprofen IP 400mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 20 Box 160392000 Tablet 1751400
37 1100Isosorbide Dinitrate
Tablets 10mgIP
Each Sublingual Tablet contains:
Diluted Isosorbide Dinitrate IP
eq. to Isosorbide Dinitrate 10 mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 200000 Yes 30 Box 9851000 Tablet 44000
38 1107 Mefloquine
Tablet 250mgIP
Each Tablet contains:
Mefloquine Hydrochloride IP
eq. to Mefloquine 250mg
Box of 10x10 Tab. In
Aluminium Foil Strip/
Blister
with Alu.back
2 Years 25000 Yes 20 Box 32000 Tablet 300
39 1108Metformin
Tablets 500mgIP
Each Coated Tablet contains:
Metformin Hydrochloride IP 500 mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 20 Box 202367000 Tablet 1135300
40 1110Methyldopa
Tablets 250mg IP
Each Coated Tablet contains:
Anhydrous Methyldopa IP 250mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes 20 Box 1169000 Tablet 63700
41 1112Metoclopramide
Tablets 10mgIP
Each Tablet contains:
Metoclopramide Hydrochloride IP
eq.
to Anhydrous Metoclopramide 10mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 5188000 Tablet 12500
42 1113Metronidazole
Tablets 400mgIP
Each Coated Tablet contains:
Metronidazole IP 400mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 20 Box 129541000 Tablet 1859400
43 1114Metronidazole
Tablets 200mgIP
Each Coated Tablet contains:
Metronidazole IP 200mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 100000 Yes 20 Box 39359000 Tablet 279400
44 1119Norethisterone
Tablets 5mg IP
Each Tablet contains:
Norethisterone IP 5mg
Box of 10x10 Tab. In
Alu. Foil Strip ($)2 Years 100000 Yes 100 Box 1920000 Tablet 42500
45 1120Norfloxacin Kid
Tablets 100mg ---
Each Dispersible Tablet contains:
Norfloxacin IP 100mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 200000 Yes 20 Box 14336000 Tablet 99400
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
46 1121Norfloxacin
Tablets 400mgIP
Each Tablet contains:
Norfloxacin IP 400mg
Box of 100x10 Tab. In
Alu. Foil Strip/ Blister
with Alu.back
2 Years 400000 Yes 20 Box 41557000 Tablet 1108100
47 1124Ofloxacin
Tablets 200mgIP
Each Tablet contains:
Ofloxacin (Calculated on Dried
basis) IP 200 mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 400000 Yes 200 Box 33629000 Tablet 686000
48 1127Paracetamol
Tablets 500mg IP
Each Tablet contains:
Paracetamol IP 500mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 20 Box 743218000 Tablet 4358000
49 1134Prednisolone
Tablets 5mgIP
Each Tablet contains:
Prednisolone IP 5mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 30 Box 24606000 Tablet 228500
50 1135Primaquine
Tablets 2.5mgIP
Each Coated Tablet contains:
Primaquine Phosphate IP
eq.to Primaquine 2.5mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes 200 Box 2729000 Tablet 14700
51 1148Quinine Tablets
300mgIP
Each Coated Tablet contains:
Quinine sulphate IP 300mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 50000 Yes 100 Box 206000 Tablet 12100
52 1149Quinine Tablets
100mgIP
Each Coated Tablet contains:
Quinine sulphate IP 100mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes 100 Box 152000 Tablet 5200
53 1152Risperidone Tablets
2mgUSP
Each Tablet contains:
Risperidone USP 2mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 200000 Yes 50 Box 14698000 Tablet 59500
54 1154Salbutamol Tablets
4mg IP
Each Tablet contains:
Salbutamol Sulphate IP
eq.to Salbutamol 4mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 45792000 Tablet 72800
55 1155Sodium Valproate
Tablets 200mgIP
Each Enteric coated Tablet contains:
Sodium Valproate IP 200 mg
Box of 100x10 Tab. In
Alu.Foil Strip2 Years 400000 Yes 20 Box 58442000 Tablet 1034400
56 1156Sodium Valproate
Tablets 500mgIP
Each Enteric coated Tablet contains:
Sodium Valproate IP 500 mg
Box of 10x10 Tab. In
Alu.Foil Strip ($)2 Years 100000 Yes 50 Box 5930000 Tablet 249100
57 1158Spironolactone
Tablets 25mgIP
Each Tablet contains:
Spironolactone IP 25 mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes 200 Box 9889000 Tablet 261700
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
58 1167TrifluoperazineHCL
Tablets 5mgIP
Each Tablet contains:
Trifluoperazine Hydrochloride IP 5
mg
Box of 10x10 Tab. In
Alu. Foil Strip ($)2 Years 200000 Yes 100 Box 2855000 Tablet 18100
59 1168
Trimethoprim &
Sulphamethoxazole
(clotrimazole tablet)
Tab 480mg
IP
Each Tablet contains:
(1)Trimethoprim IP 80mg &
(2) Sulphamethoxazole IP 400mg
Box of 100x10 Tab. In
Blister with Alu.back2 Years 400000 Yes 20 Box 104357000 Tablet 1403600
60 1171Vitamin A Capsules
50,000 IU
IP/
USP
Each Soft Gelatin Capsule contains:
Vitamin A USP/IP 50000 IU
Box of 10x10 Cap. In
Blister with Alu.back ($)2 Years 100000 Yes 100 Box 6733000 Capsule 105300
61 1172Vitamin A Capsules
2,00,000 IU
IP/
BP/
USP
Each Soft Gelatin Capsule contains:
Vitamin A USP/BP/IP 200000 IU
Box of 10x10 Cap. In
Blister with Alu.back ($)2 Years 100000 Yes 100 Box 21434000 Capsule 198000
62 1173 Vitamin B Complex
Tablets (Therapeutic)---
Each Tablet contains:
Thiamine Hydrochloride IP 5mg;
Riboflavine IP 5mg; Pyridoxine
Hydrochloride IP 2mg; Niacinamide
IP 50mg; Calcium Pantothenate IP
5mg
Product Permission as NFI or NFI
Formula will be eligible subject to
above composition only.
Box of 100x10 Tab. In
Aluminium Foil Strip 2 Years 400000 Yes 20 Box 377147000 Tablet 2181100
63 1178Fluconazole
Tablets 50mgIP
Each Tablet contains:
Fluconazole IP 50mg
Box of 10x10 Tablet In
Aluminium Foil Strip ($)2 Years 100000 Yes 100 Box 7159000 Tablet 92500
64 1182Salbutamol Rotacaps
200mcg---
Each Rotacap contains:
Salbutamol Sulphate IP eq.to
Salbutamol 200mcg
Box of 10x30 Rotacaps
with Rotahaler ($)2 Years 100000 Yes 20 Box 2022000 Rotacap 32600
65 1185Azithromycin Tablets
500mgIP
Each Coated Tablet contains:
Azithromycin IP 500mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 400000 Yes 100 Box 48118000 Tablet 4958600
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
66 1198Atorvastatine Tablets
10 mgIP
Each Tablet contains:
Atorvastatine Calcium eq. to
Atorvastatine IP 10mg
Box of 100x10 Tab. In
Alu. foil strip2 Years 400000 Yes 100 Box 71108000 Tablet 458600
67 1199Cefixime Tablet
200mgIP
Each Film Coated Tablet contains:
Cefixime IP as Trihydrate eq. to
Anhydrous Cefixime 200 mg
Box of 10x10 Tab. In
Blister with Alu.back($)2 Years 400000 Yes 100 Box 62428000 Tablet 3848600
68 1200Diclofenec Sodium
Suppository 12.5mg---
Each Suppository contains:
Diclofenec Sodium IP 12.5mg.,
Suppository base q.s.
Box of 20x5
Suppositories
In Blister with Alu.back
($)
2 Years 100000 Yes 100 Box 294000 Suppository 27300
69 1202EsCitalopram Oxalate
Tablets 10mgIP
Each Film Coated Tablet contains:
EsCitalopram Oxalate IP
eq.to EsCitalopram 10mg
Box of 100x10 Tab. In
Blister with Alu.back 2 Years 200000 Yes 30 Box 5420000 Tablet 56100
70 1203Lorazepam
Tablet 2mg
BP/
USP
Each Tablet contains:
Lorazepam BP/USP 2mg
Box of 10x10 Tab. In
Blister with Alu.back($)2 Years 200000 Yes 100 Box 7699000 Tablet 35800
71 1204Metoprolol
Tablets 25mgIP
Each Tablet contains:
Metoprolol Tartrate IP 25mg
Box of 10x10 Tab. In
Blister with Alu.back($)2 Years 200000 Yes 200 Box 29848000 Tablet 120900
72 1205Olanzapine
Tablet 5mgIP
Each Coated Tablet contains:
Olanzapine IP 5mg
Box of 10x10 Tab. In
Blister with Alu.back($)2 Years 200000 Yes 100 Box 8519000 Tablet 48500
73 1208Misoprostol
Tablet 200mcg---
Each Uncoated Tablet contains:
Misoprostol 200mcg.
Box of 25x4 Tablets In
Blister with Alu.back ($) 2 Years 100000 Yes 100 Box 2862000 Tablet 106300
74 1213Paracetamol Kid
Tablets 125mg---
Each Dispersible Tablet contains:
Paracetamol IP 125mg.
Box of 10x10 Tab. In
Blister with Alu.back($)2 Years 400000 Yes 200 Box 57050000 Tablet 175300
75 1214Aceclofenac
Tablets 100mgIP
Each Coated Tablet contains:
Aceclofenac IP 100mg.
Box of 100x10 Tab. In
Blister with Alu.back 2 Years 400000 Yes 50 Box 82365000 Tablet 436100
76 1218Levofloxacin
Tablets 500mgIP
Each Film Coated Tablet contains:
Levofloxacin Hemihydrate IP
eq. to Levofloxacin 500mg.
Box of 10x10 Tab. In
Blister with Alu.back ($) 2 Years 100000 Yes 100 Box 17178000Tablet 786500
77 1221Losartan Potassium
Tablets 50mgIP
Each Film Coated Tablet contains:
Losartan Potassium IP 50mg.
Box of 10x10 Tab. In
Blister with Alu.back ($) 2 Years 200000 Yes 200 Box 21418000 Tablet 142800
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
78 1224Pantoprazole
Tablets 40mgIP
Each Enteric Coated Tablet contains:
Pantoprazole Sodium Sesquihydrate
eq.to Pantoprazole 40mg.
Box of 10x10 Tab. In
Blister with Alu.back ($) 2 Years 400000 Yes 100 Box 98835000 Tablet 1286800
79 1226Glimepiride Tablets
1mgIP
Each Uncoated Tablet contains:
Glimepiride IP 1 mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 50000 Yes 100 Box 22069000 Tablet 103500
80 1230Artemether &
Lumefantrine Tablets ---
Each Tablet contains: Artemether
IP 80mg, Lumefantrine 480mg
Box of 5x6 Tab. In
Blister with Alu.back ($)2 Years 15000 Yes 100 Box 87000 Tablet 12100
81 1240 Spironolactone
Tablets 100mg IP
Each Tablet contains:
Spironolactone IP 100mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes 100 Box 1002000 Tablet 108200
82 1242Clopidogrel
Tablets 75mgIP
Each Coated Tablet contains:
Clopidogrel IP 75mg
Box of 10x10 Tab. In
Alu. foil strip ($) 2 Years 200000 Yes 100 Box 8480000 Tablet 158000
83 1243Levothyroxine
Tablets 50mcg IP
Each Scored Tablet contains:
Anhydrous Levothyroxine IP 50mcg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 200000 Yes 100 Box 131000 Tablet 1000
84 1244Levothyroxine
Tablets 100mcg IP
Each Scored Tablet contains:
Anhydrous Levothyroxine IP 100mcg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 200000 Yes 100 Box 138000 Tablet 1000
85 1249Tramadol
Capsules 50mgIP
Each Capsule contains:
Tramadol HCL IP 50mg.
Box of 10x10 Cap. In
Blister with Alu.back ($) 2 Years 200000 Yes 100 Box 8206000 Capsule 82200
86 1250Tramadol
Capsules 100mgIP
Each Capsule contains:
Tramadol HCL IP 100mg.
Box of 10x10 Cap. In
Blister with Alu.back ($) 2 Years 200000 Yes 100 Box 3025000 Capsule 33600
87 1251
Zinc Sulphate
Dispersible
Tablets 20mg
---
Each Dispersible Tablet contains:
Zinc Sulphate Monohydrate eq. to
20 mg of elemental Zinc (Note: Add
sufficient sweetening & flavouring
agents
& Tablet should be score)
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 100000 Yes 100 Box 147335000 Tablet 116900
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
88 1253Deferasirox Tablets
250mg---
Each Tablet for oral suspension
contains: Deferasirox 250mg
Bottle of 30 Tab./
Strip of 3x10
Tab.(30Tab.)
2 Years 100000 Yes100
Bottle740000 Tablet 277500
89 1254Deferasirox Tablets
500mg---
Each Tablet for oral suspension
contains: Deferasirox 500mg
Bottle of 30 Tab./
Strip of 3x10
Tab.(30Tab.)
2 Years 100000 Yes100
Bottle2230000 Tablet 1137300
90 1257Atorvastatin
Tablets 40mgIP
Each Tablet contains: Atrovastotin
calcium eq. to Atorvastatin IP 40mg.
Box of 10x10 Tab. In
Alu. Foil ($)2 Years 100000 Yes 100 Box 17567000 Tablet 410500
91 1258Bisacodyl
Suppository IP
Each Suppository contains:
Bisacodyl IP 5mg Suppository base
q.s.
Box of 20x5
Suppositories
In Blister with Alu.back
($)
2 Years 50000 Yes 100 Box 261000 Suppository 37600
92 1260Diclofenac Sodium
Suppository 50mg---
Each Suppository contains:
Diclofenac Sodium IP 50 mg,
Suppository base q.s
Box of 20x5
Suppositories
In Blister with Alu.back
($)
2 Years100000
Yes 100 Box 280000 Suppository 27600
93 1262
Iron and Folic acid
tablet
Blue IFA (Large)-
WIFS
IP
Each Enteric Coated Blue coloured
(Indigo Carmine) Tablet contains:
Dried Ferrous Sulphate IP eq.to
Ferrous Iron 100mg &
Folic Acid IP 0.5mg
Box of 100x15 Tab. In
Blister with Alu.back2 Years
400000 Yes 20 Box 487906000 Tablet 1805300
94 1268Oseltamivir Capsule
75mg IP
Each Capsule contains:
Oseltamivir Phosphate IP 75mg
Box of 10x10 Cap. In
Alu. Foil Strip/Blister
with
Alu.back($)
2 Years 100000 Yes 100 Box 3590000 Capsule 2328100
95 1266 Acetyl Salicylic Acid
Tablet 350mg
IP/BP
/
USP
Each Tablet contains:
Acetyl Salicylic Acid IP 350mg
Box of 10x10 Tab. In
Aluminium Foil Strip ($) 2 Years 200000 Yes 100 Box 1214000 Tablet 10600
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
96 1269Nifedipine Sustain
Release Tablet 10mgIP
Each Sustained Release Film Coated
Tablet contains: Nifedipine IP 10mg.
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 200000 Yes 100 Box 4489000 Tablet 37700
97 1270Carvedilol
Tablet 12.5mgIP
Each Film Coated Tablet contains:
Carvedilol 12.5mg
Box of 10x10 Tab. In
Alu. Foils Strip ($) 2 Years 100000 Yes 100 Box 1162000 Tablet 32700
98 1271Fluconazole
Tablet 150mgIP
Each Tablet contains:
Fluconazole IP 150mg
Box of 10x10 Tab. In
Blister with Alu.back ($)2 Years 200000 Yes 100 Box 20896000 Tablet 670800
99 1272Cefadroxil
Tablet 500mgIP
Each Tablet contains:
Cefadroxil IP eq.to 500 mg
of Anhydrous Cefadroxil
Box of 10x10 Tab. In
Aluminium Foil Strip ($)2 Years 400000 Yes 50 Box 422666000 Tablet 28427200
100 1273Iron Folic Acid (IFA)
Tablet (Small)pink IP
Each Enteric Coated Tablet contains:
Elementary Iron IP 45mg and
Folic acid IP 400 mcg.
Box of 100x10 Tab. In
Blister with Alu.back2 Years 800000 Yes 30 Box 752692000 Tablet 2145200
101 1276Famotidine Tablets
40mgIP
Each Tablet contains:
Famotidine IP 40mg
Box of 100x14 Tab. In
Blister with Alu.back2 Years 400000 Yes 20 Box 221224000 Tablet 1099800
102 1277Famotidine Tablets
20mgIP
Each Tablet contains:
Famotidine IP 20mg
Box of 100x14 Tab. In
Blister with Alu.back2 Years 400000 Yes 50 Box 315426000 Tablet 907000
103 1300Clobazam Capsule
5mg
IP/
BP/
USP
Each Capsule contains:
Clobazam IP 5mg
Box of 10x10 Cap. In
Alu. Foil Strip/Blister
with Alu.back ($)
2 Years 100000 Yes 100 Box 2273000 Capsule 188200
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
104 1307
Kit3/ White Clr
Benzathine Penicillin
Inj
& Azithromycin Tab
---
Kit3/ White Colour Each Kit
Containing 1 Vial Injection of
Benzathine Penicillin (2.4MU) &
Strip of 1 Tablet of
Azithromycin IP 1 gm.
Each Kit Containing
Injection Benzathine
Penicillin (2.4MU) 1 Vial
+
Strip of Tablet
Azithromycin
IP 1 gm OD. Such 10 Kits
should be Packed in a
Box.
2 Years --- Yes ---- 124000 Tablet 1000
105 1312Oseltamivir Capsule
30mgIP
Each Capsule contains:
Oseltamivir Phosphate IP 30mg.
Box of 10x10 Cap. In
Alu. Foil Strip/Blister
with
Alu.back($)
2 Years 100000 Yes 100 Box 720000 Capsule 36700
106 1321Tab. Aripiprazole
15mg
IP/BP
/
EUP/
USP
Each Dispersible Tablet contains:
Aripiprazole 15 mg.
Box of 10x10 Tab. In
Aluminium Foil
Strip/Blister
with Alu.back ($)
2 Years 200000 Yes 50 Box 834000 Tablet 20800
107 1326
Tab. Methyl
Phenidate
10mg
---
Each Tablet contains:
Methyl Phenidate Hydrochloride 10
mg
Box of 10x10 Tab. In
Aluminium Foil
Strip/Blister
with Alu.back ($)
2 Years 200000 Yes 50 Box 213000 Tablet 11100
108 1328Tab. Atomoxetine
18mg
IP/BP
/
EUP/
USP
Each Tablet contains:
Atomoxetine 18 mg
Box of 10x10 Tab. In
Aluminium Foil
Strip/Blister
with Alu.back ($)
2 Years 200000 Yes 50 Box 369000 Tablet 13600
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
109 1336Cap. Atazanavir
300mg---
Each Capsule contains:
Atazanavir IP 300 mg.
Bottle of 30 Tablet duly
sealed with plastic plug/
diagram and should
contain
silicon packs.tightly
fitting
suitable screw cap.
2 Years --- Yes --- as may be required 1000
110 1340
Tab. ZL Baby
(Zidovudine 60mg +
Lamivudine 30mg)
---
Each Film Coated Tablet contains:
Zidovudine IP 60mg and
Lamivudine IP 30mg.
Bottle of 60 Tablet duly
sealed with plastic plug/
diagram and should
contain
silicon packs.tightly
fitting
suitable screw cap.
2 Years --- Yes --- as may be required 1000
111 1342Tab. Nevirapine
50mg IP
Each Tablet contains:
Nevirapine IP 50mg.
Bottle of 30 Tablet duly
sealed with plastic plug/
diagram and should
contain
silicon packs.tightly
fitting
suitable screw cap.
2 Years --- Yes --- as may be required 1000
112 1343Tab. Lopinavir 100mg
& Ritonavir 25mgIP
Each Tablet contains:
Lopinavir IP 100mg &
Ritonavir IP 25mg.
Bottle of 60 Tablet duly
sealed with plastic plug/
diagram and should
contain
silicon packs.tightly
fitting
suitable screw cap.
2 Years --- Yes --- as may be required 1000
113 1344
Abamune L Baby
(Abacavir 60mg &
Lamivudine 30mg)
---
Each Film Coated Tablet contain:
Abacavir IP 60mg and
Lamivudine IP 30 mg
Bottle of 60 Tablet duly
sealed with plastic plug/
diagram and should
contain
silicon packs.tightly
fitting
suitable screw cap.
2 Years --- Yes --- as may be required 1000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
114 1352Tab.Nitazoxanide
500mg---
Each Tablet contain:
Nitazoxanide 500 mg
Box of 10x10 Tab. In
Aluminium Foil
Strip/Blister
with Alu.back ($)
2 Years --- Yes --- as may be required 1000
115 1357
Levothyroxine
Tablets
25mcg
IPEach Scored Tablet contains:
Anhydrous Levothyroxine IP 25 mcg
Box of 10x10 Tab. In
Blister with Alu back ($)2 Years --- Yes --- 113000 Tablet 1000
116 1358Labetalol Tablet
50mg
Each Tablet contains:
Labetalol 50 mg
Box of 10x10 Tab. In
Blister with Alu back ($).2 Years
200000 Yes 100 Box 234000 Tablet 1000
117 1360Oseltamivir Capsule
45mgIP
Each Capsule contains:
Oseltamivir Phosphate IP 45 mg.
Box of 10x10 Cap. In
Alu. Foil Strip/Blister
with
Alu.back($)
2 Years 100000 Yes 100 Box 720000 Capsule 36700
118 2003
Amikacin Sulphate
Injection 500 mg
(For IM/IV Use)
IP
Each 2ml contains:
Amikacin Sulphate IP
eq.to Amikacin 500mg
Box of 10x2ml Vial 2 Years 10000 Yes 100 Box 3092000 Vial 853400
119 2004
Amikacin Sulphate
Injection 100 mg
(For IM/IV Use)
IP
Each 2ml contains:
Amikacin Sulphate IP
eq.to Amikacin 100mg
Box of 10x2ml Vial 2 Years 10000 Yes 100 Box 689000 Vial 60100
120 2005
Aminophylline
Injection
2.5% w/v
(For IV Use)
IP
Each 10 ml contains:
Equal amount of Anhydrous
Aminophylline IP 250mg
Box of 25x10ml Amp 2 Years 3000 Yes 30 Box 207000 Amp 18800
121 2007
Amoxycillin &
Clavulanic
Acid Injection 300mg
IP
Each Vial contains:
Amoxycillin Sodium IP
eq.to Amoxycillin 250mg &
Clavulanate Potassium IP
eq.to Clavulanic Acid 50mg
Box of 10 Vial 2 Years 3000 Yes 50 Box 233000 Vial 80200
122 2010
Ampicillin Sodium
Injection 500 mg
(IM/Slow IV Use)
IP
Each Vial contains:
Ampicillin Sodium IP
eq.to Ampicillin 500mg
Box of 10 Vial 2 Years 10000 Yes 100 Box 632000 Vial 74000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
123 2012
Anti-D (RHO)
Immunoglobulin
(Human)
Injection 300mcg
(liquid)
IP/BP
/
USP/
EUP
Each Vial contains:
Anti-D (RHO) Immunoglobulin
(Human) 300 mcg
One Vial Individually
Packed2 Years 300 Yes 100 Box 24000 Vial 1503400
124 2013Artemether Injection
80mg---
Each ml contains:
Artemether 80 mgBox of 10x1ml Amp 2 Years 2000 Yes 100 Box 22000 Amp 11400
125 2014
Atracurium Besilate
Injection 10 mg/ml
(For IV/Infusion Use)
IP/
USP/
BP
Each ml contains:
Anhydrous Atracurium
Besilate 10mg
Box of 5x2.5ml Amp 2 Years 5000 Yes 200 Box 232000 Amp 139400
126 2015Atropine Sulphate Inj.
(for IM/IV use)IP
Each ml contains:
Atropine Sulphate IP 0.6mgBox of 25x1ml Amp 2 Years 10000 Yes 100 Box 1776000 Amp 74000
127 2019Bupivacaine HCL
Injection (20ml Vial)IP
Each ml contains:
Anhydrous Bupivacaine
Hydrochloride IP 0.5% w/v
Box of 10x20ml Vial 2 Years 3000 Yes 20 Box 106000 Vial 64000
128 2023
Cefazoline Sodium
Injection 500 mg
(For IM/IV/Infusion)
IP
Each vial contains:
Cefazoline Sodium IP
eq.to 500mg of Cefazoline
Box of 10 Vial 2 Years 2000 Yes 50 Box 82000 Vial 31600
129 2027
Ceftazidime for
Injection 1 gm
(For Deep IM/Slow
IV Infusion)
IP
Each vial contains:
Ceftazidime (Pentahydrate) IP
eq.to 1gm of Ceftazidime
Sodium; Carbonate or Argenine q.s.
Box of 10 Vial 2 Years 3000 Yes 50 Box 49000 Vial 40300
130 2029
Ceftriaxone for
Injection 500 mg
(For Deep IM/Slow
IV Infusion)
IP
Each vial contains:
Ceftriaxone Sodium IP
eq.to Anhydrous Ceftriaxone 500mg
Box of 10 Vial 2 Years 3000 Yes 50 Box 852000 Vial 146800
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
131 2031
Chloroquine
Phosphate
Injection 40 mg/ml
(For IM/Slow IV Use)
IP
Each ml contains:
Chloroquine Phosphate IP
eq.to Chloroquine 40mg
Box of 25x5ml Amp 2 Years 10000 Yes 50 Box 227000 Amp 18400
132 2032
Pheniramine Maleate
Injection
(For IM/IV Use)
IP
Each ml contains:
Pheniramine Maleate IP 22.75 mg,
Water for Injection IP q.s
Box of 25x2ml Amp 2 Years 10000 Yes 100 Box 2935000 Amp 123300
133 2039
Dexamethasone
Sodium
Injection (For IM/IV
Use)
IP
Each ml contains:
Dexamethasone Sodium Phosphate
IP
eq.to Dexamethasone Phosphate 4mg
Box of 25x2ml Amp 2 Years 10000 Yes 100 Box 3277000 Amp 262800
134 2046
Diatrizoate
Maglum.& Diat.
Sod.Inj. 60%
IP/
BP/
USP/
EUP
Each ml contains:
(i) Sodium Diatrizoate 80mg
(ii) Meglumine Diatrizoate 520mg
(Total Iodine Conc.292mg/ml
i.e.60%)
Box of 5x20ml Amp 2 Years 2000 Yes 50 Box 5000 Amp 13100
135 2047
Diatrizoate
Maglum.& Diat.
Sod.Inj. 76%
IP/
BP/
USP/
EUP
Each ml contains:
(i) Sodium Diatrizoate USP 100mg
(ii) Maglumine Diatrizoate USP
660mg
(Total Iodine conc.370mg/ml
i.e.76%)
Box of 5x20ml Amp 2 Years 2000 Yes 50 Box 25000 Amp 71300
136 2048
Diazepam Injection
5 mg/ml (For IM/IV
Use)
IPEach ml contains:
Diazepam IP 5mgBox of 25x2ml Amp 2 Years 10000 Yes 100 Box 765000 Amp 62800
137 2049
Diclofenac Sodium
Injection 25 mg/ml
(For IM Use)
IPEach ml contains:
Diclofenac Sodium IP 25mgBox of 25x3ml Amp 2 Years 10000 Yes 100 Box 9804000 Amp 423500
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
138 2050
Dicyclomine HCL
Injection 20 mg/2 ml
(For Deep IM Use)
IP/BP
/
USP/
EUP
Each ml contains:
Dicyclomine Hydrochloride 10mg
(Isotonic solution)
Box of 25x2ml Amp 2 Years 10000 Yes 100 Box 1605000 Amp 69300
139 2056
Dobutamine
Hydrochloride
Injection 50 mg/ml
(For IV Infusion)
USP
Each ml contains:
Dobutamine Hydrochloride USP
eq.to Dobutamine 50mg
Box of 5x5ml Amp 2 Years 3000 Yes 200 Box 197000 Amp 81900
140 2057
Dopamine
Hydrochloride
Injection 40 mg/ml
USPEach ml contains:
Dopamine Hydrochloride USP 40mgBox of 5x5ml Amp 2 Years 3000 Yes 200 Box 355000 Amp 76400
141 2059
Eteophylline &
Theophylline
Injection
----
Each 2 ml contains:
Etophylline IP 85/ BP 169.40mg
Theophylline IP 50.60 mg
Box of 25x2ml Amp 2 Years 10000 Yes 100 Box 3399000 Amp 153000
142 2061
Fentanyl Citrate
Injection
(For
IM/IV/Transdermal
Use)
IP
Each ml contains:
Fentanyl citrate IP eq.to
50 mcg of Fentanyl
Box of 10x2ml Amp 2 Years 10000 Yes 100 Box as may be required 1000
143 2065Frusemide Injection
For (IM/slow IV use)IP
Each ml contains:
Frusemide IP 10 mgBox of 25x2ml Amp 2 Years 10000 Yes 100 Box 1666000 Amp 90000
144 2073
Haloperidol
Injection
(For IM/IV Use)
IP
Each ml contains: Haloperidol IP 5
mg
(It is a sterile solution of Haloperidol
in
lactic acid diluted with Water For
Inj.)
Box of 25x1ml Amp 2 Years 5000 Yes 50 Box 79000 Amp 4900
145 2074Heparin Injection (For
IV/SC Use)IP
Each ml contains: Heparin Sodium
IP
eq.to Heparin 5000 units
Box of 10x5ml Vial 2 Years 2000 Yes 100 Box 274000 Vial 429100
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
146 2075
Hepatitis B Vaccine
10mcg/0.5 ml (1ml
Amp)
IP
Mfgd. by Recombinant DNA
Technology Strength of
Vaccine 20mcg/ml
1 ml Amp/Vial
Individually packed2 Years 1000 Yes
200
Amp/Via
l
35000 Amp/Vial 38900
147 2076
Hepatitis B Vaccine
10mcg/0.5ml (10ml
Vial)
IP
Mfgd. by Recombinant DNA
Technology Strength of
Vaccine 20mcg/ml
10ml Vial Individually
packed2 Years 1000 Yes 200 Vial 3000 Vial 18600
148 2079
Hydrocortisone
Sod.Succinate Inj
100mg
IP
Each vial contains: Hydrocortisone
Sodium Succinate IP eq.to
Hydrocortisone 100mg
Box of 10 Vial 2 Years 5000 Yes 100 Box 784000 Vial 243400
149 2088
Ketamine
Hydrochloride
Injection 50mg
(Deep IM/slow IV
use)
IP
Each ml contains:
Ketamine Hydrochloride IP eq.to
Ketamine 50 mg
Box of 10x10ml Vial 2 Years 2000 Yes 50 Box 55000 Vial 105400
150 2090
Lignocaine &
Adrenaline
Injection 30ml Vial
IP
Each ml contains: (i) Lignocaine
Hydrochloride IP 20mg; (ii)
Adrenaline
bitartrate IP eq.to Adrenaline
0.01mg.
Box of 10x30ml Vial 2 Years 5,000.00 Yes 20 Box 96000 Vial 25900
151 2097
Lyophilised
Antisnake
Venom Serum
(snake venom
antiserum Powder)
IP
Powder eq.to 10 ml of purified &
conc.globulin from serum of horses
immunised against four poisonous
snakes of India.
10 ml Vial Individually
packed2 Years 1000 Yes 100 Vial 148000 Vial 2220000
152 2107 Inj. Mephenteramine
15mg/ml IP
Each ml contains:
Mephentermine Sulphate IP 15mgBox of 25x1ml Amp 2 Years 10000 Yes 100 Box 97000 Amp 12100
153 2108
Methotrexate
Injection
50mg/2ml
IPEach ml contains:
Methotrexate IP 25mg
2ml Vial Individually
packed2 Years 10000 Yes 100 Vial as may be required 1000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
154 2109
Methyl Ergometrine
Maleate Inj (For
SC/IM/IV Use)
IP
Each ml contains:
Methyl Ergometrine Maleate IP 0.2
mg
Box of 25x1ml ambour
coloured glass Amp2 Years 10000 Yes 100 Box 400000 Amp 38400
155 2111
Metoclopramide
Hydrochloride
Injection (For IM/IV
Use)
IP
Each 2 ml contains: Anhydrous
Metoclopramide Hydrochloride IP
10mg
Box of 25x2ml Amp 2 Years 10000 Yes 100 Box 505000 Amp 10600
156 2117Inj. Gas Gangrene
AntitoxineIP
Each vial contains: Clostridium
Perfrigens antitoxin 10,000 IU,
Clostridium Oedematiens antitoxin
10,000 IU, Clostridium Septicum
antitoxin 5,000 IU.
One Vial Individually
Packed2 Years 400 Yes 100 Vial 4000 Vial 108000
157 2122
Neostigmine
Methylsulphate Inj
(For SC/IM/IV Use)IP
Each ml contains:
Neostigmine Methylsulphate IP
0.5mg
Box of 25x1ml Amp 2 Years 10000 Yes 100 Box 553000 Amp 53900
158 2128Paracetamol Injection
150mg/ml---
Each ml contains:
Paracetamol IP 150 mgBox of 25x2ml Amp 2 Years 10000 Yes 100 Box 3217000 Amp 277900
159 2129
Pentazocine Injection
(For SC/IM/SLOW
IV Use)
IP
Each ml contains: Pentazocine
Lactate
IP eq.to Pentazocine 30 mg
Box of 25x1ml Amp 2 Years 10000 Yes 100 Box 795000 Amp 77300
160 2135
Pralidoxime Chloride
Injection (For
IM/SLOW IV
infusion Use)
IPEach vial contains:
Pralidoxime Chloride IP 1 gm
One Unit Individually
packed with Drug Vial &
20ml Amp of Sterile WFI
IP
2 Years 1000 Yes1000
Unit165000 Vial 331700
161 2138Promethazine HCL
InjectionIP
Each ml contains: Promethazine
Hydrochloride IP 25mgBox of 25x2ml Amp 2 Years 10000 Yes 100 Box 457000 Amp 21100
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
162 2141
Quinine
Dihydrochloride
(For SLOW IV Use)
IPEach ml contains: Quinine
Dihydrochloride IP 300mg.Box of 25x2ml Amp 2 Years 5000 Yes 100 Box 19000 Amp 7800
163 2143Ranitidine Injection
50mg/2mlIP
Each ml contains: Ranitidine
Hydrochloride IP eq.to Ranitidine
25mg
Box of 25x2ml Amp 2 Years 10000 Yes 100 Box 11655000 Amp 472000
164 2145
Sodium Bicarbonate
Injection (For IV
infusion Use)
IPSodium Bicarbonate IP 7.5% (To be
used directly or diluted before use)Box of 25x10ml Amp 2 Years 5000 Yes 30 Box 331000 Amp 29400
165 2151
Sterile Vancomycin
Hydrochloride
Injection (For SLOW
IV Use)
IP
Each vial contains: Vancomycin
Hydrochloride IP eq.to
Vancomycin 0.5 gm.
One Vial Individually
Packed2 Years 3000 Yes 500 Vial 277000 Vial 322000
166 2153
Sterile Water for
Injection
(5ml)
IPEach Amp.Contain Sterile Water For
Injection 5 mlBox of 25x5ml Amp 2 Years 10000 Yes 50 Box 6156000 Amp 249300
167 2160
Immunoglob. T.T.
Human
Injection 250 IU
IP/BP
/
USP/
EUP
Tetanus Immunoglobulin has a
potency
of not less than 100 IU of Tetanus
Antitoxin per ml
One Vial/Amp containing
250 IU Individually
packed
2 Years 500 Yes
100
Vial/Am
p
15000 Amp/Vial 364500
168 2162
Tetanus Vccine
(Adsorbed) human
(For deep IM
Use)Injection
IP
Each 0.5ml Amp /Vial contains:
Tetanus toxoid not less than 5 Lf
and not more than 25 Lf
Box of 10x0.5ml
Amp/Vial2 Years 10000 Yes 100 Box 2516000 Amp/Vial 634000
169 2164
Thiopentone Sodium
Injection
500mg (For IV Use)
IPEach Vial contains:
Thiopentone Sodium IP 0.5 gmBox of 10 Vial 2 Years 5000 Yes 50 Box 73000 Vial 41600
170 2168Vacuronium Bromide
Injection (for I.V. use)---
Each Vial/Amp contains:
Dried Vacuronium Bromide USP 4
mg
Box of 10 Amp/Vial
Individually packed2 Years 2000 Yes 100 Box 146000 Amp/Vial 83600
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
171 2173
Vitamin B Complex
Injection (For IM
Use)
---
Each ml contains: Vit.B1 IP10mg;Vit.B2
IP 2mg; Vit.B6 IP 2mg; Niacinamide IP
100mg; Di-panthenol 5mg
Box of 25x2ml Amp 2 Years 10000 Yes 100 Box 840000 Amp 72600
172 2186Multivitamin
Injection (IV Use)---
Each ml contains: Vitamin A (as
Palmitate) IP 1000 IU; Cholcelciferol
(Vit. D3) IP 100 IU; Alphatocophen
phenyl acetate IP 0.5mg; Ascorbic
acid IP 50mg; Thiamin HCL 5mg;
Ribofulvin Phosphate sodium IP
1.4mg;
Nicotinamide IP 10mg; Pyridoxin
HCL
IP 1.5mg; D-Penthonol USP 2.5mg;
Water For Inj. IP q s
Box 25x10ml Amp 2 Years 5000 Yes 30 Box 1685000 Amp 293200
173 2190
Vitamin B12
Injection(Cyanocobal
amin Injection)
IPEach ml contains:
Cyanocobalamin IP 500mcg.Box of 25x1ml Amp 2 Years 10000 Yes 100 Box 903000 Amp 61000
174 2195
Glycopyrrolate
Injection
(For IM/IV Use)
USPEach ml contains:
Glycopyrrolate USP 0.2mgBox of 25x1ml Amp 2 Years 3000 Yes 100 Box 527000 Amp 71700
175 2197Iohexol Injection (For
I.V.use)USP
Each ml contains: Iohexol USP
755mg
eq. to Iodine 350mg
50ml Vial/Bottle
Individually packed2 Years 1000 Yes
100
Vial/Bott
le
12000 Bottle 130100
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
176 2198
Methyl Prednisolone
Sodium Succinate for
Injection
(Powder)(For Slow IV
Infusion)
USP
Each vial contains: Methyl
Prednisolone
Sodium Succinate USP 500mg
One Vial Individually
Packed2 Years 1000 Yes 500 Vial 145000 Vial 497600
177 2203
Sodium Chloride
Injection 100 ml
(For.I.V. use)
IPcontains:
Sodium chloride IP 0.9% w/v
100ml FFS Bottle packed
inpoly bag.(FFS Means
Plastic Bottle Mfg.Under
Form Fill & Seal
Technology
in Aseptic Environment)
2 Years 5000 Yes100
Bottle3988000 Bottle 801600
178 2213
Meropenem
Injections
500mg.(Powder form
reconstitution &
I.V.use only)
IP
Each Vial contain:
Meropenem trihydrate IP/USP
eq. to Anhydrus Meropenem 500mg.
One Vial Individually
Packed2 Years 1000 Yes 200 Vial 247000 Vial 502200
179 2214
Levofloxacin
Injection
(500mg/100ml) For
I.V. use.
IP
Each 100ml contains:
Levofloxacin Hemihydrate IP eq. to
Levofloxacin 500mg,
Dextrose IP(Anhydrous) 5%w/v,
Water For Injection IP q.s.
100ml FFS Bottle packed
inpoly bag.(FFS Means
Plastic Bottle Mfg.Under
Form Fill & Seal
Technology
in Aseptic Environment)
2 Years 5000 Yes100
Bottle449000 Bottle 207400
180 2215Aciclovir Injections
250mg (Dry Powder)IP
Each Vial contain:
Aciclovir (as sodium) IP 250mg.Box of 10 Vial 2 Years 2500 Yes 100 Box 151000 Vial 73400
181 2217
Fat Emulsion
Injections
20% w/v (PL/TG
Ratio 0.06) 250ml
---
Intravenous 20% Fat Emulsion with
size of the particles same as that of
Chylomicrons
250ml Glass/Plastic
Bottle
with Pharmacopoeial
quality
2 Years 1000 Yes 50 Bottle 12000 Bottle 79200
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
182 2219Amino Acid 10%
Injection ---
Intravenous 10% Amino Acid
Solution
Unique combination of all Essential,
Non Essential & Semi Essential
Amino Acids.
500ml Glass/Plastic
Bottle
with Pharmacopoeial
quality
2 Years 1000 Yes 25 Bottle 33000 Bottle 248500
183 2227Enoxaparin Sodium
Injection 60mg/0.6ml
IP/BP
/
USP/
EUP
Each Pre-filled syringe contains:
Enoxaparin sodium ph. Eur. 60mg
Water for Injection I.P. q.s. to 0.6ml
One Pre-filled syringe
Individually packed 2 Years 500 Yes
100
Pre-filled
syringe
223000 Pre-filled
syringe682400
184 2228Iron Sucrose Injection
(For I.V. use)
IP/BP
/
USP/
EUP
Each 5 ml Amp contains: Elemental
Iron (as Iron sucrose) 100mg,
Water For Injection q.s.
Pack of 5x5ml Amp 2 Years 1000 Yes 100 Pack 2492000 Amp 875200
185 2229
Sulbactum &
Cefoperazone
for Injection 1gm
---
Each Vial contains: Sulbactum
sodium
USP eq.to sulbactum 0.5gm,
Cefoperazone sodium IP eq.to
Cefoperazone 0.5 gm
One Vial Individually
Packed2 Years 2000 Yes 500 Vial 1220000 Vial 529600
186 2242Tramadol Injection
50mg/ml---
Each ml contains:
Tramadol IP 50mg. Box of 25x2ml Amp 2 Years 5000 Yes 100 Box 2435000 Amp 116800
187 2248
Atropine Sulphate
Injection (For
IM/IV Use)
IPEach ml contains:
Atropine Sulphate IP 0.6mg
30 ml vial
Individually Pack ($$).2 Years 3000 Yes 200 Vial 53000 Vial 55700
188 2250
Cisplatin Injection 10
mg
(Intravenous Infusion)
IP/BP
/
USP/
EUP
Each vial contains:
Cisplatin 10 mg
1 unit individually
pack.($$)2 Years 2000 Yes 500 Vial 4000 Vial 5900
189 2251
Cisplatin Injection 50
mg
(Intravenous Infusion)
IP/BP
/
USP/
EUP
Each vial contains:
Cisplatin 50 mg
1 unit individually
pack.($$)2 Years 1000 Yes 500 Vial 13000 Vial 73700
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
190 2254
Hydroxyethyl Starch
6%w/v (Intravenous
Infusion)
---
Each 100ml contains: Hydroxyethyl
starch 6gm, Sodium Chloride 900mg;
Electrolytes (mEq/L): Sodium 154,
Chloride 154; Osmolarity(calculated)
308-309 mOsmol/L; WFI q.s.
500ml FFS Bottle packed
inpoly bag.(FFS Means
Plastic Bottle Mfg.Under
Form Fill & Seal
Technology
in Aseptic Environment)
2 Years 2000 Yes 25
Bottle 22000 Bottle 107400
191 2255
Phytomenadione
(Vit.K1)
Inj. (For SC
/IM/SLOW IV Use)
IP/BP
/
USP/
EUP
Each ml contains:
Phytomenadione IP/BP/USP/EUP
1mg
Box of 10x0.5ml Amp 2 Years 10000 Yes 100 Box 740000 Amp 199000
192 2258
Bupivacaine
Hydrochloride
Injection (Heavy)
(For Spinal
anaesthesia)
USP
Each ml contains: Anhydrous
Bupivacaine Hydrochloride IP
0.5%w/v
& Dextrose Monohydrate IP 80mg
Box of 25x4ml Amp 2 Years 2000 Yes 50 Box 238000 Amp 50000
193 2271Filgrastim 300mcg
Injection---
Each vial contains:
Filgrastim 300mcg
One Vial Individually
Packed2 Years 2000 Yes 100 Vial 8000 Vial 35500
194 2275Valethamate Bromide
Injection---
Each Amp Contains:
Valethamate Bromide 8 mgBox of 25x1ml Amp 2 Years 10000 Yes 200 Box 266000 Amp 23900
195 2290Lorazepam Inj. (for
IM/IU use)USP
Each ml contains:
Lorazepam USP 1 mg.Box of 10x2ml Vial/Amp 2 Years 2000 Yes 50 Box 116000 Amp/Vial 9700
196 2291Olanzapine Inj.
(for IM use) ---
Each vial contains:
Olanzapin 10 mgBox of 10 Vial 2 Years 2000 Yes 50 Box 10000 Vial 1000
197 2292Flupenthixol depot Inj
(For deep Im use) ---
Each ml contains:
Flupenthoixol depot 20mgBox of 10x1 ml Amp 2 Years 2000 Yes 50 Box 9000 Amp 56200
198 2293
Zuclopenthixol
Decanoate
Injection 200 mg
IP/BP
/
EUP/
USP
Each ml contain:
Zuclopenthixol decanoate
200 mg
Box of 10X1 ml Amp 2 Years 1000 Yes 50 Box 8000 Amp 38400
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
199 2294
Desferrioxamine
Mesylate
Injection 500mg
IP
Each vial contains:
Desferrioxamine Mesylate IP
500mg for injection
Box of 10 Vial 2 Years 2000 Yes 50 Box 161000 Vial 729300
200 2300Ulinastatin Injection
1,00,000 IUANY
Each vial contains:
Ulinastatin 100000 IU.
One Vial Individually
Packed2 Years 500 Yes 50 Box 6000 Vial 342000
201 2303Nadroparin Injection
0.6ml ---
Each 0.6 ml vial contains:
Nadroparin Injection 0.6 ml
One Vial Individually
Packed2 Years 500 Yes 50 Box 3000 Vial 45000
202 2310 Inj Ganciclovir
600mg
Each vial contains:
Ganciclovir 600 mgBox of 10 Vial 2 Years --- Yes --- as may be required 1000
203 2311
Sodium Chloride Inj
1000ml
(For IV infusion)
IPcontains:
Sodium chloride IP 0.9% w/v
1000ml FFS Bottle
packed
inpoly bag.(FFS Means
Plastic Bottle Mfg.Under
Form Fill & Seal
Technology
in Aseptic Environment)
2 Years 5000 Yes 25 Bottle 1127000 Bottle 1000
204 2312 Cyclophosphamide
Injection 1 Gm IP
Each Vial contains:
Cyclophosphamide 1 gm
One Vial Individually
Packed2 Years 500 Yes 50 Box 3000 Vial 1000
205 2313
Fluro-Uracil
Injection
500mg/10ml
IPEach Amp contains:
Fluro-Uracil IP 500mg
10 ml Amp Individually
Packed2 Years 500 Yes 50 Box 5000 Amp 1000
206 2314
Inj Balance Salt
Solution
(Glass Bottle) 500 ml
IP
Contains:
Sodium chloride IP 0.49 % w/v,
Pottasium Chloride IP 0.075 % w/v,
Calcium chloride IP 0.048% w/v,
Magnesium chloride, WFI IP q.s.
500 ml glass Bottle
Individually packed2 Years --- Yes
500
Bottleas may be required 1000
207 3002
Albendazole
Suspension
200 mg/5 ml (10 ml
Bottle)
---Each 5 ml contains:
Albendazole IP 200 mg.
10 ml Bottle Individually
pack($)2 Years 5000 Yes
300
Bottle10170000 Bottle 277800
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
208 3013
HbSAg-Rapid Test Kit for
detection of Hepatitis B
surface Antigen (HbSAg)
in Plasma/Serum
--- Composition/Specifications:
As per Annexure
ONE TEST UNIT
(Kit containing upto 100
Test)
2 Years --- Yes --- 1165000 Test 213200
209 3015
Betamethasone Valerate
CreamIP/BP
/
EP/
USP
Contains: Betamethasone Valerate
BP/EP/USP/IP eq.to 0.05% of
Betamethasonein a suitable cream
base
15 gm Tube Individually
packed($)2 Years 10000 Yes 500 Tube 5734000 Tube 903000
210 3024
Chloroquine
Phosphate
Syrup 100 mg/10ml
IP
Each 5 ml contains:
Chloroquine Phosphate IP 80 mg
eq.to Chloroquine 50 mg.
60 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 5000 Yes100
Bottle373000 Bottle 64200
211 3026
Cholecalciferol
Granules
(Vitamin D3)
---Each Alluminium Sachet contains:
Cholecalciferol IP 60,000 I.U.
One Alluminium sachet
hermetically sealed (light
resistant) in which the air
has
been replaced by
nitrogen/
inertgas. ($)
2 Years 5000 Yes1000
Sachet2228000 Sachet 198000
212 3028 Clotrimazole Cream 1% IP Contains: Clotrimazole IP 1% w/w15gm Tube Individually
packed($)2 Years 10000 Yes 500 Tube 7405000 Tube 941900
213 3029
Compound Benzoic
Acid
Ointment
(Whitefield's oint.)
IP
Contains: Benzoic acid IP 6% w/w
Salicylic Acid IP 3% w/w
Emulsifying base q.s.
30gm Tube Individually
packed($)2 Years 5000 Yes 500 Tube 2712000 Tube 635000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
214 3030
Vitamin A Solution
Conc.
100000 IU/1ml
IP
Each ml contians:
Vitamin A IP 100000 IU
Vitamin A Solution is
yellow/brownish
yellow oily liquid containing suitable
agents such as antioxidants.
The quality of Vitamin A, vegetable
oil
and stabilizing agent should confirm
to
the requirement of IP
100ml Amber Colored
Bottle individually
packed
with 2ml spoon with
marking at 1ml
2 Years 1000 Yes 50 Bottle 952000 Bottle 591500
215 3033
Dextromethorphan
Syrup
13.5 mg/ 5 ml
IP
Each 5 ml contains:
Dextromethorphan
Hydrobromide IP 13.5 mg
60 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 5000 Yes100
Bottle11686000 Bottle 1832800
216 3037
Dicyclomine HCL
Oral
Solution 10 mg/5ml
IPEach 5 ml contains:
Dicyclomine Hydrochloride IP10 mg
30 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 10000 Yes100
Bottle1363000 Bottle 172600
217 3065Halothane Liquid
250ml Bottle--- ---
250 ml Amber Coloured
tightly closed Bottle
Individually packed.
2 Years 500 Yes 25 Bottle 2000 Bottle 69000
218 3068
Hydrogen Peroxide
Solution 200 ml
Bottle
IPHydrogen Peroxide
Solution 6% (20 volume)
200 ml Amber Coloured
Plastic Bottle.($)2 Years 2000 Yes 50 Bottle 315000 Bottle 74800
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
219 3070Ibuprofen Suspension
100 mg/5 ml
IP/BP
/
USP
Each 5 ml contains:
Ibuprofen IP/BP/USP 100mg.
50 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 5000 Yes100
Bottle2962000 Bottle 269800
220 3073Isoflurane Liquid
(100 ml)
BP/
EP/
USP
---
100 ml Amber Coloured
tightly closed glass Bottle
Individually packed
2 Years 500 Yes 25 Bottle 4000 Bottle 43200
221 3088Paracetamol Syrup
125 mg/5 mlIP
Each 5 ml contains:
Paracetamol IP 125 mg.
60 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 5000 Yes100
Bottle7517000 Bottle 1179200
222 3090Petroleum Jelly
(White)IP --- 1 Kg. Metal Tin 2 Years 500 Yes 15 Tin 65000 Tin 296900
223 3100
Povidone Iodine
Solution
5% 1 Litre Jar
IPContains: Povidone Iodine IP 5% w/v
(Available Iodine (I) 0.5%)
1 Litre "A" type Plastic
Jar/Pet Bottle2 Years 1000 Yes 16 Bottle 174000 Bottle 355000
224 3105
Salbutamol Syrup
2 mg/5 ml
100ml Bottle
IP
Each 5 ml contains:
Salbutamol Sulphate IP
eq. to Salbutamol 2mg.
100ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 3000 Yes100
Bottle4049000 Bottle 522300
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
225 3106Sevoflurane Liquid
with quick fill adaptor--- ---
250 ml Bottle
Individually
packed
2 Years 100 Yes 20 Bottle 11000 Bottle 1389500
226 3107
Silver Sulphadiazine
Cream 1%
500 gm Jar
BP/
EP/
USP
Contains: Silver Sulphadiazine USP
1%
500 gm Amber colour
wide
mouth Jar wrapped in
black
paper.
2 Years 1000 Yes 20 Jar 150000 Jar 616500
227 3109Sodium Hypochlorite
Solution 5 Liter Jar
BP/
EP/
USP
Contains: Not less than 4% & not
more
than 6% by weight of Naclo.
5 Liter tightly closed light
resistant "A" type plastic
container.
2 Years 1000 Yes 4 Jar as may be required 1000
228 3111
Reagent Strips for
Estimation of
Albumin &
Glucose in Urine
---
Opaque, Plastic Reagent strips with
two
filter papers affixed to them,
one is impregnated with indicator &
buffer for the estimation of Albumin
Bottle of 50 Strips
Individually packed. ($$)2 Years 2000 Yes
100
Bottleas may be required 1000
{Protein} in Urine & another with
enzymes & chonogen for quantitative
estimation of Glucose in Urine.
Yes
229 3114 Timolol Maleate
Eye Drops 0.25% IP
Contains: Timolol Maleate IP
eq.to Timolol 0.25%
5ml FFS Vial (plastic
container) with screw cap
spike ($)
2 Years 500 Yes 500 Vial 89000 Vial 13400
230 3117
Trimethoprim &
Sulphamethoxazole
Oral Suspension
IP
Each 5 ml contains:
Trimethoprim IP 40 mg
Sulphamethoxazole IP 200 mg
50 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 5000 Yes100
Bottle4082000 Bottle 614200
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
231 3131 Calamine Lotion IP
Contains: Calamine IP 150gm, Zinc
Oxide IP 50gm, Bentonite IP 30gm,
Sodium Citrate IP 5gm, Liquified
Phenol IP 5ml, Glycerin IP 50ml,
Purified Water to produce 1000ml
30ml Plastic Bottle ($$) 2 Years 5000 Yes200
Bottle1371000 Bottle 279700
232 3138
HCV Elisa Test Kit
Hepatitis C virus antibody
detection 3rd Generation
test (ELISA)
--- Composition/Specification:
As per Annexure
ONE TEST UNIT
(Kit containing upto 96
Tests)
2 Years --- Yes --- 611000 Test 178700
233 3139
HCV Rapid Test Kit
Hepatitis C Virus 3rd
Generation Test (Rapid) ---
Composition/Specification:
As per Annexure
ONE TEST UNIT
(Kit containing upto 100
Test)
2 Years --- Yes --- 308000 Test 202700
234 3142
Povidone Iodine
Ointment
5% (20gm Tube)
BP/
EP/
USP
Contains:Povidone Iodine IP 5% w/w
(Available iodine 10% of
thestrength) Water soluble
base...Q.S.
20gm Tube Individually
packed($)2 Years 5000 Yes 500 Tube 3622000 Tube 775800
235 3143
Pregnancy Test Kit
(HCG Dipstick) (50
Test)
--- Composition/Specification:
As per Annexure
ONE TEST UNIT
(Kit containing upto 50
Tests)
2 Years --- Yes --- 6782000 Test 333400
236 3157
Serum VDRL Test
Kit
(RPR Flocculation
Test)
--- Composition/Specification:
As per Annexure
ONE TEST UNIT
(Kit containing upto 100
Test)
2 Years --- Yes --- 2723000 Test 66300
237 3158
Serum Widal Test Kit
(Rapid Slide Test)
(4x5ml)
--- Composition/Specification:
As per Annexure
ONE TEST UNIT
(Kit of 4x5ml)2 Years --- Yes --- 490000 Test 20400
238 3159
Silver Sulphadiazine
Cream
1% (20gm tube)
BP/
EP/
USP
Contains: Silver Sulphadiazine
BP/EP/USP 1% w/w
20gm Tube Individually
packed($)2 Years 3000 Yes 500 Tube 1293000 Tube 314200
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
239 3162
Azithromycin Oral
Suspension
200mg/5ml
IPEach 5 ml contains:
Azithromycin IP 200mg15ml Bottle ($$) 2 Years 10000 Yes
200
Bottle2120000 Bottle 516700
240 3168
Diazepam Rectal
Solution
2mg/ml
BP
Each ml contains: Diazepam IP 2mg,
Benzyl Alcohol IP 1.5% w/v,
Sodium Benzoate IP 1% w/v
Unit of 2.5ml vial with
applicator Individually
packed($)
2 Years 1000 Yes 500 Unit 3000 Vial 1000
241 3175
Compound Benzoin
Tincture 500 ml
Bottle
IP
Contains:
Benzoin IP 100gm(in moderately
coarse
powder); Prepared Storax IP 75mg;
Tolu Balsam IP 25gm; Aloes IP
20gm
(in moderately coarse powder);
Ethanol
(90%) IP sufficient to produce
1000ml
500ml Amber Coloured
Bottle2 Years 2000 Yes
20
Bottle24000 Bottle 78200
242 3183Clobetasol Propionate
CreamIP
Contains:
Clobetasol Propionate IP 0.05%
W/W
15 gm Tube Individually
packed($)2 Years 10000 Yes 500 Tube 3156000 Tube 614500
243 3200
Levocetirizine
Dihydrochloride
Syrup
30 ml Bottle
---
Each 5ml contains:
Levocetirizine Dihydrochloride IP
2.5mg
Flavoured Syrup base….. q.s.
30 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 10000 Yes200
Bottle5084000 Bottle 667800
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
244 3202Permethrin Cream 5%
30gm Tube---
Each gm contains: Permethrin 50mg.
Preservative formaldehyde solution
BP 1mg. Cream base q.s.
30gm Tube Individually
Packed ($)2 Years 5000 Yes 500 Tube 258000 Tube 82800
245 3203Lactulose Solution
100 ml Bottle
IP/BP
/
USP/
EUP
Each 5ml contains: Lactulose
Concentrate IP/BP/USP/EUP eq.to
lactulose 3.35 gm, Aqueous base q.s.
100ml Bottle Individually
Packed ($$)2 Years 2000 Yes
100
Bottle275000 Bottle 334100
246 3207Cephalexin Syrup
125 mg/5 mlIP
Each 30ml Bottle contains:
Anhydrous cephalexin IP 750mg.
30 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 5000 Yes100
Bottle1524000 Bottle 358900
247 3209Glycerine 100 ml
BottleIP
Each Bottle contains: Glycerine IP
100ml 100ml PET Bottle ($$) 2 Years 5000 Yes
100
Bottle215000 Bottle 91500
248 3211Magnesium Sulphate
Powde--- Magnesium Sulphate IP 500gm. Box of 500gm 2 Years --- Yes 100 Box 11000 Box 5900
249 3214
Petroleum Jelly
(White)
30 gm Tube
---Each Tube contains:
Petroleum Jelly (White) 30gm.
30gm Tube Individually
Packed ($)2 Years 5000 Yes 300 Tube 1395000 Tube 367900
250 3216Zinc Gluconate Syrup
20 mg/ml---
Each ml contains:
Zinc Gluconate 20mg.
60 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years 10000 Yes100
Bottle1154000 Bottle 301200
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
251 3224
Cyclopentolate Eye
Drop
5ml
USP/
BP/
EUP
Each ml contains:
Cyclopentolate HCL
USP/BP/EUP 1% w/v
5ml FFS Vial (Plastic
container) with screw cap
spike ($)
2 Years 5000 Yes 500 Vial 70000 Vial 21000
252 3225
Lignocaine HCL Jelly
5%
30gm Tube
USP/
BP/
EUP
Contains:
Lignocaine Hydrochloride 5% w/w
30gm Tube Individually
Packed2 Years 5000 Yes
500
Tube 235000 Tube 211500
253 3227
Moxifloxacine Eye
Drop
5ml
IPContains:
Moxifloxacin HCL IP 0.5% w/v
5ml FFS Vial (Plastic
container) with screw cap
spike ($)
2 Years 5000 Yes 500 Vial 606000 Vial 961700
254 3230
Prednisolone Acetate
Eye
Drop 0.1%, 5ml
USP/
BP/
EUP
Contains:
Prednisolone Acetate
USP/BP/EUP/IP 0.1% w/v
5ml FFS Vial (Plastic
container) with screw cap
spike ($)
2 Years 5000 Yes 500 Vial 42000 Vial 1000
255 3231
Tobramycine Eye
Drop
0.3% w/v, 10ml
USP/
BP/
EUP
Contians:
Tobramycin USP/BP/EUP 0.3% w/v
10ml FFS Vial (Plastic
container) with screw cap
spike ($)
2 Years 5000 Yes 500 Vial 126000 Vial 1000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
256 3232Iron Folic Acid
(IFA) Syrup---
1 ml of Iron Folic Acid (IFA) Syrup
should contains 20mg elementary
Iron
and 100 mcg folic acid.
Each Bottle should be of
100ml & it should have
on
autodispenser so that only
1ml of syrup will be
dispensed
at a time.(IFA
information
leaflet as per annexure in
the
mono-cartoon of IFA
Syrup)
2 Years 5000 Yes100
Bottle1840000 Bottle 457600
257 3234
Dianoprostone Gel
3%
3gm
---
Each Pre-filled Syringe contains:
Dinoprostone BP 0.5 mg in a suitable
base.
3 gm Pre-filled syringe 2 Years 2000 Yes
500
Pre-
fiilled
Syringe
105000 Pre-fiilled
Syringe537400
258 3236
Clotrimazole with
Beclomethasone EAR
Drops 1% Any
Each ml contains: Clotrimazole IP
1%
with Beclomethasone Dipropionate
IP
0.025% Drops
5ml Vial (Plastic
container)
with screw cap spike ($)
2 Years 50000 Yes 500 Vial 407000 Vial 256400
259 3237
Neomycin,
Hydrocortisone
& Polymixin B Ear
Drops
---
Each ml contains:
Neomycin Sulphate eq.to 3400 IU
Neomycin base, Polymixin B 10000
IU,
Hydrocortisone 5 mg
5ml FFS Vial (Plastic
container) with screw cap
spike ($)
2 Years 50000 Yes 500 Vial 498000 Vial 418300
260 3238
Brimonidine Tartrate
and
Timolol Eye Drops
0.15% + 0.5%
---
Each ml contains:
Brimonidine Tartrate 0.15% w/v &
Timolol Maleate 0.5% w/v
5ml FFS Vial (Plastic
container) with screw cap
spike ($)
2 Years 10000 Yes 500 Vial 36000 Vial 91800
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
261 3240
Tobramycin and
Dexamethasone
Ophthalmic
Suspension
0.3%+0.1%
---
Each ml contains:
Dexamethasone 0.1% w/v &
Tobramycin 0.3% w/v
5ml FFS Vial (Plastic
container) with screw cap
spike ($)
2 Years 25000 Yes 500 Vial 93000 Vial 16700
262 3244
Hydroxypropyl
Methylcellulose 2%. Each ml contains:
Hydroxypropyl Methylcellulose
Soln 20 mg
5ml FFS Vial (Plastic
container) with screw cap
spike ($)
2 Years 3000 Yes 100 Vial 54000 Vial 108500
263 3245
Neomycin Sulphate,
Polymyxine B
Sulphate,
Bacitracon Zinc
Powder
(10gm)
---
Each gram contains:
Polymyxin B Sulphate 5000 Units,
Bacitracin Zinc IP 400 Units,
Neomycin Sulphate IP eq to
Neomycin
3400 Units
10 gm Powder
Individually
Packed.($)
2 Years 5000 Yes 500 No. 864000 No. 421200
264 3246
Artemether &
Lumefantrine
Syrup (Pediatric)
(15ml Bottle)
---
Each 5ml contains:
Artemether IP 40 mg &
Lumefantrine 240 mg
15 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($)
2 Years 3000 Yes100
Bottle2000 Bottle 700
265 3315
Syrup Lopinavir (80
mg/ml)
+ Ritonavir
(20mg/ml)
(160ml Bottle)
---
Each ml contains:
Lopinavir 80 mg &
Ritonavir 20 mg
160 ml Plastic Bottle of
PET/
PETG or
Polypropylene(PP)
with Pharmacopoeial
quality
($$)
2 Years --- Yes --- as may be required 1000
266 4004Adhesive Zinc Tape
5cmx10mtrUSP
Each Roll of size:
5cmx10mtrCylinder of 6 Rolls 2 Years 1000 NA
20
Cylinder409000 Roll 474000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
267 4005Adhesive Zinc Tape
7.5cmx10mtrUSP
Each Roll of size:
7.5cmx10mtrCylinder of 4 Rolls 2 Years 1000 NA
20
Cylinder199000 Roll 358200
268 4007Blood Administration
Set (ETO)---
As per IS No: 9824-1981 and as
amended from time to time Sterilised
by ETO method with airway
One Set Individually
Packed
(Such 25 Set should be
packed in polythene bag)
2 Years 5000 NA 500 Set 503000 Set 82200
269 4009Crepe Bandage Pack
(10cmx4mtr)BP Roll of 10cmx4mtr
One Roll Individually
Packed
(Such 10 Roll should be
packed in a box/ poly
bag)
2 Years 3000 NA 80 Roll 396000 Roll 354000
270 4010Crepe Bandage Pack
(6cmx4mtr)BP Roll of 6cmx4mtr
One Roll Individually
Packed
(Such 10 Roll should be
packed in a box/ poly
bag)
2 Years 3000 NA 100 Roll 187000 Roll 105500
271 4011
Disposable
Hypodermic
Needle Size: 22x1"
---
Sterile Hypodermic Needles for
single
use,as per IS:10654:2002 as amended
from time to time.
Box of 100 Needle
Individually
Blister Strip Packed with
medical grade paper
2 Years 20000 NA 60 Box 20357000 Needle 265700
272 4013
Disposable
Hypodermic
Needle Size: 23x1"
---
Sterile Hypodermic Needles for
single
use,as per IS:10654:2002 as amended
from time to time.
Box of 100 Needle
Individually
Blister Strip Packed with
medical grade paper
2 Years 20000 NA 60 Box 30980000 Needle 404300
273 4015
Disposable
Hypodermic
Needle Size: 24x1"
---
Sterile Hypodermic Needles for
single
use,as per IS:10654:2002 as amended
from time to time.
Box of 100 Needle
Individually
Blister Strip Packed with
medical grade paper
2 Years 20000 NA 60 Box 31640000 Needle 412900
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
274 4017Infusion Set
(E.T.O.Sterilised)---
As per IS
No:12655,Sterile,Disposable,
Nontoxic, Nonpyrogenic,sterilised by
ETO radiation method,With
bulblatex;
molded dripping chamber &
Siliconized
good quality needle Size: 21Gx1.5";
Daimeter (I.D.) of tube 2.7 to
3.00mm;
Length of Tube: 150 cms.
One Set Individually
Packed
(Such 25 Set should be
packed in polythene bag)
2 Years 10000 NA 500 Set 21041000 Set 2506000
275 4019
Disposable Syringe
10 ml
(Without Needle)
---
Natural,Vergin Plastic Syringes as
per
IS 10258:2002 as amended
from time to time
Box of 50 Syringe
Individually
Blister Strip packed with
medical grade paper
2 Years 10000 NA 20 Box 22788000 Syringe 1292100
276 4020
Disposable Syringe 2
ml
(Without Needle)
---
Sterile Single Use Syringes as per
IS:10258:2002 as amended
from time to time
Box of 100 Syringe
Individually
Blister Strip packed with
medical grade paper
2 Years 10000 NA 30 Box 39746000 Syringe 1026600
277 4021
Disposable Syringe 5
ml
(Without Needle)
---
Sterile Single Use Syringes as per
IS:10258:2002 as amended
from time to time
Box of 100 Syringe
Individually
Blister Strip packed with
medical grade paper
2 Years 10000 NA 20 Box 48318000 Syringe 1464000
278 4022
Plaster Of Paris
Bandage
(10cm x 2.7mtr)
BP Roll of size: 10cm x 2.7mtr
One Roll Individually
Packed
(Such 10 Roll should be
packed in a box/ poly
bag)
2 Years 2000 NA 100 Roll 563000 Roll 239000
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
279 4023
Plaster Of Paris
Bandage
(15cm x 2.7mtr)
BP Roll of size: 15cm x 2.7mtr
One Roll Individually
Packed
(Such 10 Roll should be
packed in a box/ poly
bag)
2 Years 2000 NA 80 Roll 656000 Roll 389700
280 4024Rolled Bandage
(5mtr x 5cm)ISI
Handloom Cotton Bandage cloth
Non-sterilized, IS:863:1988 as
amended from time to time
One Roll of 5mtrx5cm
(Such 12 Rolls should be
packed in a polybag)
2 Years 2000 NA 200 Pkt 6796000 Roll 703200
281 4028
Ab.Surg.Sut.Catgut
Plain
2-0 w/o needle
USP
Length: 152 cms. Non-boilable
catgut
Plain Diameter: 2-0
Pkt. of 12 Foils 2 Years 500 Yes 100 Box 43000 Packet 23200
282 4035Ab.Surg.Sut.Catgut
Chromic 1 w/o needle
USP/
BP/
EUP
Length: 152 cms. Non-boilable
catgut
Chromic Diameter: 1
Pkt. of 12 Foils 2 Years 500 Yes 100 Box 22000 Packet 12800
283 4036Ab.Surg.Sut.Catgut
Chromic 2 w/o needleUSP
Length: 152 cms. Non-boilable
catgut
Chromic Diameter: 2
Pkt. of 12 Foils 2 Years 100 Yes 100 Box 8000 Packet 5000
284 4038
Ab.Surg.Sut.Catgut
Chromic 2-0 w/o
needle
USP
Length: 152 cms. Non-boilable
catgut
Chromic Diameter: 2-0
Pkt. of 12 Foils 2 Years 200 Yes 100 Box 19000 Packet 10300
285 4045
Ab.Sur.Sut.Chromic
2-0 with
1/2Cir.RB30mm
USP/
BP/
EUP
Length: 76 cms. Non-boilable catgut
Chromic 1/2 circle round bodied
30mm
Diameter: 2-0
Pkt. of 12 Foils 2 Years 500 Yes 100 Box 83000 Packet 47300
286 4047
Ab.Sur.Sut.Chromic
3-0 with
1/2Cir.RB20mm
USP/
BP/
EUP
Length: 76 cms. Non-boilable catgut
Chromic 1/2 circle round bodied
20mm
Diameter: 3-0
Pkt. of 12 Foils 2 Years 500 Yes 100 Box 15000 Packet 8300
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
287 4063
Ab.Sur.Sut.Polygly.
3-0
with1/2Cir.RB17mm
USP/
BP/
EUP
Length: 75 cms. Polyglycolic acid
suture
1/2 circle round bodied 17mm.
Diameter: 3-0
Pkt. of 12 Foils 2 Years 500 Yes 50 Box 18000 Packet 12200
288 4090
Non-abs.BB.Silk
sur.on
Reel 1 (25mtr)
USP Length: 25 mtrs Diameter: 1 Box of 6 Reel 2 Years 250 Yes 50 Box 31000 Box 41900
289 4120
Non-
ab.Monofi.Polyamid
3-0 3/8cir cut16mm
USP
Length: 70 cms. Monofilament
Polyamide 3/8 circle cutting 16 mm
Diameter: 3-0
Pkt. of 12 Foils 2 Years 500 Yes 100 Box 75000 Packet 32800
290 4121
Non-
ab.Monofi.Polyamid
4-0 3/8cir cut16mm
USP
Length: 70 cms. Monofilament
Polyamide 3/8 circle cutting 16 mm
Diameter: 4-0
Pkt. of 12 Foils 2 Years 500 Yes 100 Box 32000 Packet 14000
291 4179Absorbent Cotton
Wool 400gmIP ---
400 gm Packet, packed in
brown paper2 Years 1500 NA
Bale of
50 Pkt826000 Single Pkt 1677000
292 4182Disposable Needle
Size: 26x0.5"---
Sterile Hypodermic Needles for
Single
Use as per IS:10654:2002 as
amended
from time to time
Box of 100 Needle
Individually
Blister packed in medical
grade
paper
2 Years 20000 NA 60 Box 688000 Needle 11500
293 4184
Insulin Syringe 1 ml
with
graduation upto 100
units
with prefixed 28G x
1/2
---
Sterile Single Use Syringes for
Insulin as
per IS:12227:2002 as amended from
time to time
Ribbon Pack Insulin
Syringe
with needle (Such 100
No.
should pack in a Box)
2 Years 10000 NA 30 Box 3262000 Syringe 205500
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
294 4187
I.V. Cannula with
Injection
Valve Size: 16
G(E.T.O.Radiation
Method)
---
It is provided with Inj. site, & one
way
retreating valve to facilitate extra
medication & to prevent back flow.
colour coded valve cap for size
identification as per international std.
ETO Sterile & Non-pyrogenic
*:PTFE/
FEP/PU, Catheter. Silliconized
Needle
One Unit Packed
Individually
Blister strips with medical
grade paper.(Supply in a
box
of 4x25 units in a poly
bag.)
2 Years 10000 NA1000
Units38000 Unit 6700
295 4188
I.V. Cannula with
Injection
(E.T.O.Radiation
Method)
Valve Size: 18 G
---
It is provided with Inj. site, & one
way
retreating valve to facilitate extra
medication & to prevent back flow.
colour coded valve cap for size
identification as per international std.
ETO Sterile & Non-pyrogenic
*:PTFE/
FEP/PU, Catheter. Silliconized
Needle
One Unit Packed
Individually
Blister strips with medical
grade paper.(Supply in a
box
of 4x25 units in a poly
bag.)
2 Years 10000 NA1000
Units914000 Unit 126100
296 4189
I.V. Cannula with
Injection
(E.T.O.Radiation
Method)
Valve Size: 20 G
---
It is provided with Inj. site, & one
way
retreating valve to facilitate extra
medication & to prevent back flow.
colour coded valve cap for size
identification as per international std.
ETO Sterile & Non-pyrogenic
*:PTFE/
FEP/PU, Catheter. Silliconized
Needle
One Unit Packed
Individually
Blister strips with medical
grade paper.(Supply in a
box
of 4x25 units in a poly
bag.)
2 Years 10000 NA1000
Units2768000 383600
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
297 4190
I.V. Cannula with
Injection
(E.T.O.Radiation
Method)
Valve Size: 22 G
---
It is provided with Inj. site, & one
way
retreating valve to facilitate extra
medication & to prevent back flow.
colour coded valve cap for size
identification as per international std.
ETO Sterile & Non-pyrogenic
*:PTFE/
FEP/PU, Catheter. Silliconized
Needle
One Unit Packed
Individually
Blister strips with medical
grade paper.(Supply in a
box
of 4x25 units in a poly
bag.)
2 Years 10000 NA1000
Units3273000 Unit 448700
298 4191
I.V. Cannula with
Injection
(E.T.O.Radiation
Method)
Valve Size: 24 G
---
It is provided with Inj. site, & one
way
retreating valve to facilitate extra
medication & to prevent back flow.
colour coded valve cap for size
identification as per international std.
ETO Sterile & Non-pyrogenic
*:PTFE/
FEP/PU, Catheter. Silliconized
Needle
One Unit Packed
Individually
Blister strips with medical
grade paper.(Supply in a
box
of 4x25 units in a poly
bag.)
2 Years 10000 NA1000
Units2147000 Unit 345200
299 4198
Elastic Adhesive
Bandage
(E.T.O.Radiation
Method)
Size: 10cm X 2.70mtr
BP
Roll of Size width 10cm x length
2.7mtr
(After Streched length 4/6 mtrs)
One Roll Individually
Packed
in metal container with
lid
2 Years 1000 NA 100 Roll 286000 Roll 617800
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
300 4227
Foley's Catheter 8 FR
(3 to 5 CC Balloon)
(Paed)
Any
Smooth, Siliconized Rubber Latex
Catheter having self-retaining
balloon
with stiff & adequate thickness of tip.
Size and arrangement of four
drainage
eyes,valves,adepter nozzal &
capallary
tube should comply with its usage &
international std.
One Unit Packed
Individually
and must be sterilised by
Gamma Radiation/ E.T.O.
Radiation Method. (Such
100 Units should packed
in a
cardboard box)
2 Years 3000 NA 500 Nos. 42000 Unit 38700
301 4228
Foley's Catheter 10
FR
(3 to 5 CC Balloon)
(Paed)
Any
Smooth, Siliconized Rubber Latex
Catheter having self-retaining
balloon
with stiff & adequate thickness of tip.
Size and arrangement of four
drainage
eyes,valves,adepter nozzal &
capallary
tube should comply with its usage &
international std.
One Unit Packed
Individually
and must be sterilised by
Gamma Radiation/ E.T.O.
Radiation Method. (Such
100 Units should packed
in a
cardboard box)
2 Years 3000 NA 500 Nos. 32000 Unit 29500
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
302 4229
Foley's Catheter
for Adult use: 12 FR
(30 to 50CC Balloon)
(2 Way)
Any
Smooth, Siliconized Rubber Latex
Catheter having self-retaining
balloon
with stiff & adequate thickness of tip.
Size and arrangement of four
drainage
eyes,valves,adepter nozzal &
capallary
tube should comply with its usage &
international std.
One Unit Packed
Individually
and must be sterilised by
Gamma Radiation/ E.T.O.
Radiation Method. (Such
100 Units should packed
in a
cardboard box)
2 Years 3000 NA 500 Nos. 70000 Unit 36800
303 4230
Foley's Catheter
for Adult use: 14 FR
(30 to 50CC Balloon)
(2 Way)
Any
Smooth, Siliconized Rubber Latex
Catheter having self-retaining
balloon
with stiff & adequate thickness of tip.
Size and arrangement of four
drainage
eyes,valves,adepter nozzal &
capallary
tube should comply with its usage &
international std.
One Unit Packed
Individually
and must be sterilised by
Gamma Radiation/ E.T.O.
Radiation Method. (Such
100 Units should packed
in a
cardboard box)
2 Years 3000 NA 500 Nos. 239000 Unit 125500
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
304 4231
Foley's Catheter
for Adult use: 16 FR
(30 to 50CC Balloon)
(2 Way)
Any
Smooth, Siliconized Rubber Latex
Catheter having self-retaining
balloon
with stiff & adequate thickness of tip.
Size and arrangement of four
drainage
eyes,valves,adepter nozzal &
capallary
tube should comply with its usage &
international std.
One Unit Packed
Individually
and must be sterilised by
Gamma Radiation/ E.T.O.
Radiation Method. (Such
100 Units should packed
in a
cardboard box)
2 Years 3000 NA 500 Nos. 425000 Unit 223100
305 4232
Foley's Catheter
for Adult use: 18 FR
(30 to 50CC Balloon)
(2 Way)
Any
Smooth, Siliconized Rubber Latex
Catheter having self-retaining
balloon
with stiff & adequate thickness of tip.
Size and arrangement of four
drainage
eyes,valves,adepter nozzal &
capallary
tube should comply with its usage &
international std.
One Unit Packed
Individually
and must be sterilised by
Gamma Radiation/ E.T.O.
Radiation Method. (Such
100 Units should packed
in a
cardboard box)
2 Years 3000 NA 500 Nos. 151000 Unit 79300
306 4269Disposable
Syringe 20 ml---
Sterile Single Use Syringes as per
IS:10258:2002 as amended from
time to time
Box of 50 Syringe
Individually
Blister strip packed with
medical grade paper
2 Years 2000 NA 20 Box 858000 Syringe 86500
307 4270Disposable
Syringe 50 ml---
Sterile Single Use Syringes as per
IS:10258:2002 as amended from
time to time
Box of 25 Syringe
Individually
Blister strip packed with
medical grade paper
2 Years 2000 NA 20 Box 371000 Syringe 116300
Sr.
No.
Item
CodeName of Item STD Composition Packing Unit
Shelf Life
(Minimum)
Min.
Batch
Size
WHO
GMP
Packing
per
carton
2 year
Approx.
Requirement
EMD
(Rs.)
1 2 3 4 5 6 7 8 9 10 11 12
T.E.No.GMSCL/D-629/RC/2018-2019
308 4275Disposable Spinal
Needle (Size: 22G)Any
Sterile Disposable Spinal Needle of
size
22G x 3 1/2" Individually Packed,as
per
IS standard as amended from time to
time.
Box of 50 Needle
Individually
Ribbon packed
2 Years 1000 NA1000
Needle12000 Needle 8200
309 4278Disposable Spinal
Needle (Size: 23G)Any
Sterile Disposable Spinal Needle of
size
23G x 3 1/2" Individually Packed,as
per
IS standard as amended from time to
time.
Box of 50 Needle
Individually
Ribbon packed
2 Years 1000 NA1000
Needle233000 Needle 152000
310 4305
Micropore
Adhesive
Paper Tape
Each Roll of size: 1.25cms x 9.1 mtr Box of 12 Roll. 2 Years --- NA --- 435000 Roll 71800
9. Marking : Printing/marking on Kit will be as per Drug & Cosmetics Rules.
10. WHOGMP -Yes-compulsory WHOGMP Required. & NA-Not Applicalbe Column No 9.i.e.Items excluded from WHOGMP Certification.
2. For Tablet-Capsules items ($) means such 10 box should be packed in polybag /cellophen.
3. Rate contract will be/may be awarded on the basis of available information regarding approximate requirement.
4. EMD is calculated on the basis of available information of This year purchase Amount for Indent list Items/NPPA/Previous RC rate.
5. Any deviation in Packing will be mentioned in Remark Column but Rate should be quoted very carefully as per packing unit column No 6.
6. FFS vial means plastic Vial manufactured under Form Fill & Seal technology in aseptic enviornment.
N.B.
1. Minimum batchsize means the quantity stated in column No.8 or the quantity in requisition order issued rate contract whichever is less.
8. For Miscelleneous items ((Liquid preparations {Oral/External},Ointments, Eye/Ear preparations, ($) means such 10 units/tubes/vials/sachets/pkts.
7. For Miscelleneous items ((Liquid preparations {Oral/External},Ointments, Eye/Ear preparations, ($) means such 10 units/tubes/vials/sachets/pkts. should be packed in a poly
bag/cellophen/box and ($$) Means such 10 Bottles should be packed in a Box.In case of Glass Bottle Divider must be used.